Introduction {#s1}
============

Protein kinases regulate most aspects of *Eukaryotic* biology, including cell growth, differentiation, proliferation and apoptosis. They are one of the largest protein families in eukaryotes ([@bib39]); more than 500 kinases in the human genome comprise \~2% of all protein coding genes. Due to their central importance in signaling networks, kinase activity has evolved to be precisely regulated by a myriad of distinct mechanisms. A breakdown in kinase regulation is the underlying cause of many human diseases; in particular, inappropriate kinase activation drives most cancers.

Kinases have evolved a multitude of mechanisms to control their activation. Some examples such as the requirement for allosteric modulators, regulation by inhibitory interactions, and localization control are highly variable across the kinome. However, the activation of most kinases requires phosphorylation of the activation loop, a conserved structural feature that connects the N and C-terminal lobes of the kinase domain. Most serine/threonine kinases and a subset of tyrosine kinases are regulated by phosphorylation of a conserved TxY motif within this loop. This phosphorylation affects both substrate binding and the arrangement of catalytic residues ([@bib35]; [@bib50]), leading to robust regulation of enzyme activity.

Extensive structural and biochemical studies have afforded insight into the mechanisms of kinase regulation by activation loop phosphorylation. In the mitogen activated protein kinases (MAPKs) extracellular signal-regulated kinase 1 (ERK1) and ERK2, several structural elements are important for activity. These include the p+1 binding pocket that binds the substrate peptide proline, the regulatory αC helix, and the L16 loop. Upon phosphorylation of the TxY threonine and tyrosine residues, a number of changes occur. A network of electrostatic contacts with the phospho-threonine and phospho-tyrosine drives a conformation change around the p+1 substrate binding site, enabling substrate binding. The regulatory αC helix rotates inwards, allowing a glutamate on the αC helix (Glu-69) to form a salt bridge with Lysine (Lys-52) on the β3 strand that is crucial for catalytic activity. Extension of the C terminal L16 loop enables rotation of the N- and C-terminal domains, leading to 'domain closure', bringing Lys-52 closer to other catalytic residues, such as aspartates in the DFG and HRD motifs. Together, these conformational changes can lead to a 1000-fold increase in activity ([@bib67]; [@bib15]; [@bib56]). Similar conformational changes contribute to the regulation of many kinases beyond the MAPK family ([@bib32]; [@bib62]).

Some kinases are able to autophosphorylate and thus autoactivate. Multiple mechanisms for autophosphorylation have been proposed ([@bib9]). Some kinases, for example most receptor tyrosine kinases ([@bib9]) are autophosphorylated in *trans*, where distinct molecules transfer phosphates to one another. Other kinases autophosphorylate in *cis;* that is the kinase catalyzes an intramolecular transfer of phosphates onto its own TxY. In the latter case, autophosphorylation of dual-specificity tyrosine regulated kinases (DYRK) and glycogen synthase kinase-3β(GSK3β) has been proposed to occur during intermediate stages of protein folding ([@bib43]). Other mechanisms include binding to allosteric modulators that reorient the activation loop towards catalytic residues (e.g. p38α, [@bib20]) or conformational changes driven by dimerization (e.g. RAF; [@bib54]). In contrast, many other kinases require phosphorylation of the activation loop in *trans* by a distinct upstream kinase. For example, many MAPKs are dependent on phosphorylation by upstream MAPK kinases (MAPKKs) for their activation ([@bib16]).

The MAP kinases ERK1 and ERK2 exhibit very low autophosphorylation activity as purified proteins in vitro ([@bib40]; [@bib8]), and they manifest high activity in vivo only when they are phosphorylated by the upstream MAPKK, MAP/ERK kinase (MEK). ERK1 and ERK2 mutants have been described that exhibit much higher autophosphorylation activity ([@bib23]), and one such mutant can drive oncogenic transformation of cells ([@bib60]) highlighting the importance of stringent control of ERK phosphorylation.

In earlier work ([@bib30]), we used ancestral reconstruction methods to study the evolution of the specificity of the CMGC group of kinases, which include cyclin dependent kinase (CDK), MAPK, GSK, and casein kinase (CK). CDKs are major regulators of cell division ([@bib48]) and transcription ([@bib25]). MAPKs are crucial for cell proliferation, differentiation, and stress responses. As part of this study, we observed that an inferred deep ancestor of this group had high basal activity even in the absence of any activating kinase or allosteric activators. This finding was surprising given the tight control of many MAP kinases by upstream activators, and the dependence of CDKs on both cyclin binding and upstream activating kinases. Therefore, to study how suppression of autophosphorylation and thus strong dependence on upstream activating kinases evolved, we decided to investigate the regulatory evolution of the CMGC group, ultimately focusing on the MAP kinases ERK1 and ERK2.

Throughout the evolutionary history of MAP kinases, gene duplications and diversifications resulted in multiple paralogs with diverse regulation ([@bib30]). For example, within the p38 subfamilies, p38β has a much higher basal catalytic activity than p38α ([@bib8]) and within the ERK family, ERK7 is constitutively active ([@bib1]; [@bib2]), and the core kinase domain of ERK5 has a much higher autophosphorylation rate, and thus higher basal activity, than ERK1 and ERK2, which are almost completely inactive in the absence of the activating kinase MEK ([@bib14]).

Through biochemical analysis of reconstructed kinases, we found that the transition to dependence on MEK occurred between the inferred common ancestor of ERK1, 2 and 5, and that of ERK1 and 2. Through a targeted mutagenesis approach we identified the key evolutionary mutations that mediated this transition. Two changes--- mutation of the gatekeeper residue and a single amino acid deletion in the linker loop between the β3 strand and αC helix accounted for this regulatory evolution. Reversal of these inferred evolutionary mutations in modern ERK1 and ERK2 led to full autoactivation in the absence of an upstream activating kinase. Thus, we believe we have identified key steps in the regulatory evolution of the ERK MAPK family.

Results {#s2}
=======

Reconstruction of the lineage leading to ERK kinases {#s2-1}
----------------------------------------------------

To understand how kinase activity evolved, we reconstructed ancestors of the kinases leading to ERK1 and ERK2. Briefly, we collected a set of sequences for each of the major kinase families of the CMGC group. The sequences sampled for each kinase family were selected to be evenly distributed across the eukaryotic phylogeny. We then used a maximum likelihood phylogenetic method ([@bib29]) to infer the sequences of the ancestral kinases from AncCDK.MAPK from which all CDK and MAPK descend, to the inferred common ancestors of the MAPK (AncMAPK), Jnk/p38/ERK (AncJPE) and ERK families (AncERK, ([@bib30]). Posterior probabilities of the reconstructions of these four ancestral kinases are shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. In this study, we additionally generated a more focused reconstruction of ERK family kinases that reconstruct ancestors of ERKs including the inferred ancestor of ERK 1,2 and 5 (AncERK1-5), and that of ERK 1 and 2 (AncERK1-2, [Figure 1A](#fig1){ref-type="fig"}). Posterior probabilities of these reconstructions are shown in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}. The full reconstruction files for all ancestors can be accessed at <http://phylobot.com/350478581/msaprobs.PROTCATLG/ancestors>.

![Kinase activity became more tightly regulated at the transition from AncERK1-5 to AncERK1-2.\
(**A**) Phylogenetic tree for the CDK. MAPK group. The ancestral nodes corresponding to the kinases reconstructed in this study are indicated by circles. The red box indicates a transition from high basal activity to low activity in the absence of activation by MEK. (**B**) Substrate specificity of AncMAPK. Average of two replicates positional scanning peptide libraries were used to profile the specificity of the inferred ancestral kinase AncMAPK. Red indicates positive selection, blue indicates negative selection. (**C**) Quantification of the basal activities of inferred ancestral kinases and modern ERK1 with and without the activating kinase, MEK (log~10~ rate of myelin basic protein phosphorylation activity relative to ERK1), red box indicates the transition in basal activity. Error bars indicate ± SD, n = 3.](elife-38805-fig1){#fig1}

Evolution of substrate specificity in the MAP kinase lineage {#s2-2}
------------------------------------------------------------

We synthesized the coding sequences for these inferred ancestors and purified them from *E. coli*. We then used a positional-scanning peptide library (PSPL; [@bib34]) to determine the specificity of all inferred ancestors. The specificities of all inferred ancestors were consistent with expectations. As previously reported, the inferred deep ancestor of the CMGC group contained hallmarks of specificity found along multiple branches of the CMGC phylogenetic tree including +1 proline, −2 proline and −3 arginine preference. The new inferred CDK and MAPK ancestors generated for the current study lost the −3 arginine specificity at the transition to the inferred ancestor of CDK and MAPK (AncCDK.MAPK, [Figure 1---figure supplement 3A and B](#fig1s3){ref-type="fig"}). This was most likely due to the mutation of Glu to Ser in the conserved HRDxKPEN motif, previously reported to be a strong determinant of −3 arginine preference ([@bib47]). All inferred ancestors had a strong preference for proline at the +1 position including the inferred ancestor of all MAP kinases (AncMAPK, [Figure 1B](#fig1){ref-type="fig"}), as expected. Together the specificities of inferred ancestors were concordant with expectations providing confidence in our reconstructed kinases.

Regulatory evolution in the MAP kinase lineage {#s2-3}
----------------------------------------------

Next, we tested the basal activity of the reconstructed kinases using Myelin Basic Protein (MBP) as a generic substrate. We found that all inferred ancestors prior to and including AncERK1-5 had relatively high activity, while AncERK1-2 had low activity, almost comparable to modern ERK1/2 ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). One alternative possibility for this decreased phosphorylation of MBP is that kinase specificity changed such that AncERK1-2 does not efficiently recognize the MBP substrate. However, PSPL specificity arrays indicated that there was very little change in specificity from AncERK1-5 to modern ERK2 ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). We also assessed the activity of AncERK1-5 and AncERK1-2 to a second substrate, ELK1. AncERK1-2 also had had much lower activity towards EL-1 than AncERK1-5 ([Figure 1---figure supplement 5A and B](#fig1s5){ref-type="fig"}), strongly indicating a change in kinase activity, not specificity. Thus, a transition in kinase activity occurred between AncERK1-5 and AncERK1-2. Importantly, AncERK1-2 was activated \~6 fold either by coincubation with MEK ([Figure 1C](#fig1){ref-type="fig"}) or by purification from an *E. coli* strain that coexpressed MEK ([Figure 1---figure supplement 5C and D](#fig1s5){ref-type="fig"}), indicating that the decrease in activity was a regulatory evolution event rather than a general problem with kinase reconstruction leading to loss of activity for trivial reasons such as failure to fold correctly. We believe that the modest activation of AncERK1-2 by MEK is due to the high specificity this activating kinase; AncERK1-2 is likely a poor MEK substrate compared to modern ERKs 1 and 2. The decrease in activity of AncERK1-2 was due to both an increase in the Michaelis-Menten constant (K~M~) and a decrease in k~cat~ ([Table 1](#table1){ref-type="table"}, [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}). Therefore, we have identified a major transition in kinase regulation within the ERK kinase family.

###### Michaelis-Menten kinetic parameters for AncERK1-5, AncERK1-2 and ERK1 with Myelin Basic Protein as a substrate.

  Kinase      K~M~ (µM)   95% confidence interval   k~cat~ (min^-1^)   95% confidence interval
  ----------- ----------- ------------------------- ------------------ -------------------------
  AncERK1-5   1.47        1.08, 2.00                0.64               0.59 to 0.69
  AncERK1-2   40.43       32.44, 50.63              0.0011             0.0010 to 0.0012
  ERK1        9.48        6.35, 13.98               0.0065             0.0059 to 0.0072

The higher basal activity of deep inferred ancestors is due to autophosphorylation of the TxY motif {#s2-4}
---------------------------------------------------------------------------------------------------

We next aimed to determine the mechanism of the activity transition between AncERK1-5 and AncERK1-2. Almost all MAPKs have a conserved \'TxY\' motif at the activation lip in their kinase domain, and dual phosphorylation of this motif drives kinase activation. Dual phosphorylation of the threonine and tyrosine residues of \'TxY\' motif in ERK2 is catalyzed by MEK1/2. This dual phosphorylation causes the N- and C-terminal domains in ERK2 to rotate toward one another, thus organizing the catalytic sites ([@bib15]). This conformational change also promotes substrate recognition in the p+1 site ([Figure 2A](#fig2){ref-type="fig"}).

![Higher basal activity of inferred ancestors is due to autophosphorylation on the TxY motif.\
(**A**) Superposition of ERK2 (gray, Protein Data Bank code 1ERK) and phosphorylated ERK2 (tan, Protein Data Bank code 2ERK). The activation segment (ribbon diagram) and the 'TEY' motif (represented as sticks) are colored orange and yellow for ERK2, blue and red for phosphorylated ERK2. Phosphorylation of the TEY motif leads to a conformational change that remodels the activation loop to enable substrate binding, and rotation of the C helix (arrow) leading to interaction between Lys (K52) on the β3 strand and Glu (E69) on the C helix. Part of Loop L16 adopts a helical conformation in phosphorylated ERK2. (**B**) Kinase activity of wildtype and AxF mutants of inferred ancestors towards MBP. (**C**) LC-MS quantification of phosphorylation levels threonine and tyrosine in the 'TEY' motif in reconstructed ancestral kinases and ERK1. Bar graphs indicate the relative abundance of various phosphorylated forms of tryptic peptides that contain the 'TEY' motif.](elife-38805-fig2){#fig2}

Multiple sequence alignment analysis showed that the 'TxY' motif was conserved among all inferred kinase ancestors ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To test the role of the 'TxY' motif in the evolution of kinase activity, we first mutated the 'TxY' motif to 'AxF', thus removing the phosphoacceptor hydroxyl groups, rendering the motif non-phosphorylatable. These mutations greatly reduced the activity of all inferred kinase ancestors ([Figure 2B](#fig2){ref-type="fig"}), suggesting that requirement for 'TxY' phosphorylation was an early evolutionary event. Next, we quantified the phosphorylation level of threonine and tyrosine in the 'TxY' motif in reconstructed ancestral kinases and ERK1 by liquid chromatography mass spectrometry of tryptic peptides (LC-MS, [Figure 2C](#fig2){ref-type="fig"}). Consistent with the kinase activity transition, we observed that the level of phosphorylated tyrosine (Tx-pY) was relatively high in deeper inferred ancestors: AncCDK.MAPK (22.9%), AncMAPK (32.3%), AncJPE (48.1%), AncERK (76.3%) and AncERK1-5 (76.0%), and then dropped precipitously at the transition to AncERK1-2 (5.7%), which had levels similar to modern Erk1 (3.8%). Phosphorylation of threonine in the 'TxY' motif (pT-xY), followed a similar pattern of higher levels in inferred deep ancestor kinases, including AncCDK.MAPK (35.1%), AncMAPK (7.6%), AncJPE (12.4%) and AncERK (7.3%), and almost undetectable levels in AncERK1-5, AncERK1-2 and modern Erk1. Notably, we also detected di-phosphorylation of the 'TxY' motif (pT-x-pY) in the inferred deep ancestor kinases AncCDK.MAPK (6.3%), AncJPE (27.6%) and AncERK (7.9%). These results suggest that autophosphorylation at the 'TxY' loop became much less efficient in AncERK1-2, thus leading to dependence on upstream activating kinases.

Shortening of linker loop and mutation of gatekeeper residue led to tight regulation in the ERK1-2 family {#s2-5}
---------------------------------------------------------------------------------------------------------

To understand how this regulatory evolution occurred, we next sought to identify the specific mutations underlying the transition in kinase activity that occurred between AncERK1-5 and AncERK1-2. First, however, we wished to determine whether the activities of AncERK1-5 and AncERK1-2 were robust to uncertainties in ancestral sequence reconstruction. To address this issue, we synthesized alternative inferred ancestors combining all alternate residues with posterior probability \>0.2 ([@bib45]). The inferred ancestors of alternative kinases behaved similarly to the original inferred ancestors ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). The alternative ancestor Alt.AncERK1-2 had 2.5-fold higher activity than the maximum likelihood AncERK1-2, possibly due to slight differences in the activation segment and the L16 loop. Nevertheless, Alt.AncERK1-2 still has 100-fold lower activity than AncERK1-5 and both of its alternative reconstructions. These results further suggest that the transition of kinase activity occurred between AncERK1-5 and AncERK1-2 and that our results are robust to phylogenetic and reconstruction uncertainty ([@bib28]).

With this test, we were confident to compare inferred ancestors in an attempt to identify causal evolutionary mutations. As an initial strategy, we constructed a series of chimeras between AncERK1-5 and AncERK1-2. First, we divided the inferred ancestor kinases into three parts (N terminus, middle, and C terminus, [Figure 3---figure supplement 2A and B](#fig3s2){ref-type="fig"}), and shuffled these parts ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}, chimera 1--3). One strong possibility was that changes in the flexibility of the activation loop would account for differential TxY autophosphorylation. However, chimeras that swapped the middle domain of the inferred ancestors had no effect on activity. Rather, our initial chimeras indicated that changes in the N-terminus were responsible for most of the difference in the activity of these inferred ancestors ([Figure 3---figure supplement 2D](#fig3s2){ref-type="fig"}). We narrowed the causal variation using two additional chimeras ([Figure 3---figure supplement 2B and D](#fig3s2){ref-type="fig"}, chimera 4 and 5). A key advantage of ancestral reconstruction is that the number of amino acid transitions between inferred ancestors is typically far lower than the number of differences between extant proteins ([@bib64]). Therefore, after our chimera analysis there were only two possible changes to assess within the causal fragments, an insertion of an arginine after the 44^th^ amino acid (ins44R, AncERK1-2 numbering) and a transition from glutamine to methionine at the 89^th^ amino acid (Q89M, AncERK1-2 numbering). Indeed, reverting these amino acids to the inferred ancestral state in AncERK1-2 (referred to as the AncERK1-2-ins44R-Q89M mutant) was sufficient to confer high basal activity to this kinase ([Figure 3A](#fig3){ref-type="fig"}). This increased activity is almost as high as ERK1 activated by MEK, or the activated ERK1 mutant suggesting that reversion of these two evolutionary changes to the inferred ancestral state makes AncERK1-2 mostly independent of activating kinases. Adding MEK to the AncERK1-2-ins44R-Q89M does not increase the kinase activity much. Adding MEK to AncERK1-2 increases activity \~6 fold, but this leads to \< 10% of the activity of the active mutant. We believe that this inefficiency is due to the known high specificity of MEK for ERK1 and 2. We speculate that MEK doesn not recognize AncERK1-2 as efficiently as ERK1 and 2, accounting for the lower efficiency of activation of AncERK1-2. Conversely, introducing just these two mutations into AncERK1-5 (i.e. deletion of R46 and mutation of M90 to Q) suppressed basal activity to the levels of AncERK1-2 ([Figure 3---figure supplement 2C and E](#fig3s2){ref-type="fig"}). By modeling the AncERK1-2 sequence onto the Erk2 structure (PDB: 1ERK), we mapped the 44R insertion to the loop between the β3 strand and helix αC, and the Q89M mutation to the gatekeeper position at the back of the ATP-binding pocket ([Figure 3B](#fig3){ref-type="fig"}). Together, these results suggested that Q89M and ins44R were the key mutations in the evolutionary transition from high to low basal activity.

![Shortening of the linker loop and mutation of the gatekeeper residue led to tight regulation in the ERK1-2 family.\
(**A**) Kinase assays comparing the activity of two evolutionary mutants to the activity of AncERK1-2 before and after preincubation with active MEK kinase (log~10~ rate MBP phosphorylation). Error bars indicate ± SD, n = 3. (**B**) Positions of the two evolutionary mutations modeled on the ERK2 structure (PDB 1ERK). The gatekeeper residue, Q122, is shown in green, and the location of the 74N insertion is shown in red. (**C**) Phylogenetic tree indicating the state of the β3-αC insertion and identity of gatekeeper residues during evolution of the AncERK1-5 group. Numbers in the brackets indicate the posterior probability for ancestral reconstructions.](elife-38805-fig3){#fig3}

Reversing evolutionary mutations leads to activation of modern ERK1 {#s2-6}
-------------------------------------------------------------------

The β3-αC loop and gatekeeper mutations are innovations of the ERK1-2 subfamily. All the inferred ancestors prior to AncERK1-2 had a longer linker loop and a hydrophobic residue at the gatekeeper position ([Figure 3C](#fig3){ref-type="fig"}; [Figure 3---figure supplements 3](#fig3s3){ref-type="fig"} and [4](#fig3s4){ref-type="fig"}). Therefore, we wondered whether mutating these residues back to an inferred ancestral state might be sufficient to increase modern ERK1/2 activity. First, we introduced the insertion into the loop between the β3 strand and αC helix in ERK1. The insertion increased ERK1 activity more than 30-fold ([Figure 4A](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We also found that the Q122M gatekeeper mutant led to ERK1 activation ([Figure 4A](#fig4){ref-type="fig"}) and phosphorylation of the 'TEY' motif was enhanced ([Figure 4B](#fig4){ref-type="fig"}). Mutation in the gatekeeper residue has been reported to activate ERK2 in previous studies ([@bib23]), but this mutation was to ALA or GLY, therefore it is interesting that both small residues and the evolutionary mutation to a bulky polar residue activate ERK1. When we combined the loop insertion and Q122M gatekeeper mutation, the double mutant was much more active than either single mutant ([Figure 4A](#fig4){ref-type="fig"}). Indeed, the combination of these two mutations raised ERK1 activity by more than 2 orders of magnitude, almost to the levels of ERK1 after activation with MEK. Therefore, reversing just these two evolutionary changes in modern ERK1 reverts the kinase back to an inferred ancestral regulatory state with very little dependence on its upstream regulatory kinase.

![Reversing evolutionary mutations leads to activation of modern ERK1 through *cis*-autophosphorylation of the TEY motif.\
(**A**) Kinase assays measuring activity of modern ERK1 and mutants that revert the β3-αC loop length and gatekeeper residue to the inferred ancestral state (log~10~ rate of MBP phosphorylation relative to ERK1). Error bars indicate ± SD, n = 3. (**B**) Western blots indicating degree of phosphorylation of the residues in the kinase activation loop (top), Coomassie brilliant blue loading control (bottom). (**C**) Activity of ERK-ins74N mutant and its 'TEY' mutants towards MBP. (**D**) Quantification of the phosphorylation level of the 'TEY' motif in ERK1 wildtype and ins74N mutant by LC/MS analysis of tryptic peptides. (**E**) Autophosphorylation assay. 0.5 µM Erk kinase and its mutants were incubated with kinase assay buffer without substrate. The ERK1 kinase and the ins74N mutant were tagged with either His6 (lanes 1 and 2) or GST (lane 3, the GST tag was used to alter the mobility of kinase alleles allowing them to be distinguished on an SDS-PAGE gel). GST-ERK1-ins74N kinase dead K71R mutant (ins74N KD) was incubated without His6-ERK1-ins74N (lane 4), and with 0.25 µM or 0.5 µM His6-ERK1-ins74N (lanes 5 and 6).](elife-38805-fig4){#fig4}

The length of the β3-αC loop determines basal activity {#s2-7}
------------------------------------------------------

We wondered if the identity of the amino acid insertion after position 44 of ERK1 was important. Our reconstruction showed that arginine was not the only possible amino acid insertion at position 44. Asparagine was the next most likely alternative inferred ancestral amino acid at this position. Therefore, we tested an ERK1-74N insertion mutant (ins74N in ERK1 numbering) and determined this mutant to be just as active as the ERK1-74R allele. Indeed, we found that, in addition to arginine and asparagine, many other amino acid insertions also increased ERK1 activity ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Thus, we hypothesized that loop-length rather than precise amino acid identity might explain the increased kinase activity. To test this hypothesis, we inserted and deleted residues along this loop. Deletions and insertions from K72 to P75 (ERK1 numbering) greatly affected mutant activity. However, length changes after P75, had a minor effect ([Figure 4---figure supplement 2A and B](#fig4s2){ref-type="fig"}). These results confirmed the importance of loop length from K72 to P75 in the determination of ERK1 basal activity.

Increased activity in modern ERK1 is due to *cis* autophosphorylation on the TxY motif {#s2-8}
--------------------------------------------------------------------------------------

Because the 'TxY' motif was highly phosphorylated in inferred deep ancestral kinases, we hypothesized that increased 'TxY' phosphorylation would likely also be a mechanism of mutant ERK1 activation. Consistent with this idea, mutations in this motif to 'AxY', 'TxF' and 'AxF' all abolished the increased activity caused by the insertion mutation ([Figure 4C](#fig4){ref-type="fig"}). Furthermore, Western blots using an antibody specific for phosphorylated ERK ([Figure 4B](#fig4){ref-type="fig"}) and LC-MS quantification of tryptic peptides ([Figure 4D](#fig4){ref-type="fig"}) both showed elevated 'TxY' phosphorylation in mutant kinases.

The *E. coli* bacterium that we use to express ERK1 and inferred ancestral kinases lacks endogenous kinases capable of phosphorylating the 'TxY' motif. Therefore, the increased phosphorylation of 'TEY' motif is likely caused by autophosphorylation ([@bib30]). Indeed, experiments incubating kinase with ATP-y-^32^P in the absence of substrate showed that autophosphorylation rates were indeed increased in the ERK1-ins74N mutant ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Together, these results suggested that the insertion caused elevated phosphorylation of the 'TxY' motif. To test whether this autophosphorylation occurred in *cis* or in *trans*, we employed a catalytically inactivated mutant, ERK1-ins74N-K52R. We fused the kinase dead allele to GST to increase the molecular weight of this protein allowing us to distinguish it from catalytically active ERK1 on an SDS-PAGE gel. We then mixed the kinase dead allele with the activated ERK1-ins74N allele. There was no detectable phosphorylation of the kinase-dead GST-ERK1-ins74N-K52R, even though the catalytically active allele clearly continued to undergo autophosphorylation ([Figure 4E](#fig4){ref-type="fig"}). To provide further support for an intramolecular mechanism, we measured autophosphorylation rates as a function of ERK1 concentration. *Cis*-autophosphorylation should scale linearly with ERK1 concentration, while *trans*-autophosphorylation should scale as the square of ERK1 concentration. We found the former result to be true ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). These results imply that autophosphorylation occurs through an intramolecular mechanism in *cis*.

Molecular dynamics simulations reveal increased flexibility at the glycine rich loop and loop 16, and a higher probability of an active organization of catalytic residues in mutant kinases. {#s2-9}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To investigate if changes in protein dynamics might suggest mechanisms by which autophosphorylation was increased, we performed a series of ensemble molecular dynamics (MD) simulations. We focused on the unphosphorylated structure, which is only available for ERK2 (PDB ID:1ERK; [@bib15]). First, we confirmed that the evolutionary mutations identified in ERK1 also led to activation of ERK2 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Indeed, the ins55N and gatekeeper also activate ERK2, further supporting our evolutionary hypothesis. We then performed MD simulations of wild-type ERK2, the ß3-αC loop insertion mutant (ins55N, rat ERK2 numbering) in ERK2, the gatekeeper residue mutation Q103M (rat ERK2 numbering), and the double mutant (ins55N + Q103M).

We performed 1000 independent MD simulations on Folding\@home ([@bib58]) for ERK2- WT, ins55N, Q103M and the ins55N-Q103M double mutant starting from the unphosphorylated ERK2 structure (PDBID: 1ERK), which is in the inactive, 'DFG-in' conformation. These 4,000 MD simulations were propagated for a total of at least 500 μs per system, resulting in an aggregate total of \~2.05 ms of simulation time ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). For each system, we assessed multiple hypotheses for how mutations might affect *cis*-autophosphorylation. Potential mechanisms included: changes in the overall flexibility of the kinase fold, decreases in the relative distances between the key catalytic residues in the kinase active site, reorganization of the 'C-spine' and 'R-spine' ([@bib38]; [@bib62]), and a reduced domain closure angle between the N and C-terminal domains ([@bib38]; [@bib46]) (structural features are illustrated in [Figure 5A](#fig5){ref-type="fig"}). In addition, we assessed a previously suggested mechanistic pathway ([@bib23]) wherein mutations in the gatekeeper residue affect a cluster of hydrophobic interactions that change the flexibility of the 'activation lip', the part of the activation segment that contains the TEY phosphorylation motif.

![Molecular dynamics simulations of activated mutants show increased flexibility at the glycine rich loop and loop 16, and increased salt-bridge formation at the catalytic site.\
(**A**) Structure of ERK2 with relevant features annotated: L16 -- orange, Gly loop - dark orange, C spine - dark blue, R spine - light blue, gatekeeper residue -- purple, catalytic residues (K52, D147 and D165) -- red, and loop insertion position -- green. (**B--D**) Root mean square fluctuations (RMSF, error bars indicating 95% confidence intervals of the means are plotted but are too small to see): Wild type -- green, mutant -- blue and difference between mutant and WT -- red. (**B**) ERK2-ins55N (ß3-αC loop insertion mutant) (**C**) ERK2-Q103M (gatekeeper residue mutant) (**D**) ERK2-ins55N-Q103M (double mutant). (**E**) Probability density of salt-bridge between ß3-lysine and αC-glutamate, K52--E69. (**F**) Distribution of domain closure angles. (**G**) Probability density of distances \< 4 Å between Y185 of the 'TxY' motif and active site D147H: Wild type -- green, ERK2-ins55N -- blue, ERK2-Q103M -- yellow and ERK2-ins55N-Q103M -- black. (**H**). Top 100 conformations of ERK2-WT with smallest Y185-D147 distance. D147 (red) and Y185 (blue) are shown as spheres.](elife-38805-fig5){#fig5}

First, we compared the overall flexibility (indicated by the αC root mean square fluctuations, RMSF) of each mutant to WT. ERK2-ins55N showed increased flexibility at the glycine rich loop ([Figure 5B](#fig5){ref-type="fig"}), ERK2-Q103M showed increased flexibility at loop 16 (L16, [Figure 5C](#fig5){ref-type="fig"}) and the ERK2-ins55N-Q103M double mutant was more flexible at both the glycine rich loop and L16 ([Figure 5D](#fig5){ref-type="fig"}). Therefore, each mutation has subtle effects on peptide backbone dynamics and the double mutant combines both of these effects.

We next investigated the dynamics of the catalytic residues. There are several residues critical for catalysis: K52/71, D147/166 and D165/184 (rat ERK2/human ERK1 numbering) ([@bib56]). The salt bridge between the ß3-Lys52 and αC-Glu69 (K52-E69) promotes kinase activity and corresponds to the 'αC-helix in' active conformation ([@bib56]), thus the distances between these residues are informative for the expected catalytic rate of the active site. Indeed, the K52-E69 salt bridge was more frequently present in mutants than WT ([Figure 5E](#fig5){ref-type="fig"}). Next, we studied other inter-residue distances in the catalytic site, K52-D165 and E69-F166 from the DFG motif. Here, average inter-residue distances were significantly reduced in at least one of the mutants ([Figure 5---figure supplement 3A and B](#fig5s3){ref-type="fig"}). The ERK2-ins55N and ERK2-Q103M mutants both altered these average distances, and the ERK2-ins55N-Q103M double mutant was roughly the sum of the effects consistent with the additive effect of mutations observed in our experiments. This result is consistent with the idea that the catalytic site of ERK2 can more readily adopt an active conformation when reverted to the inferred ancestral state, thereby increasing the rate of autophosphorylation.

The gatekeeper residue lies between two conserved non-consecutive structural 'spines' of hydrophobic amino acids, the R- and C-spines that connect the two lobes and reorganize upon kinase activation ([@bib62]). We therefore analyzed the organization of the R-spine and C-spine. We did not observe statistically significant differences in distances along the R-spine residues between the WT and mutant simulations. However, there were some changes in C-spine distances. Distributions of these distances are plotted in [Figure 5---figure supplement 3C--E](#fig5s3){ref-type="fig"}. Gatekeeper mutations were previously shown to activate kinases through changes in the R-spine conformation ([@bib6]). However, these studies focused on activation mutations that lead to drug resistance, which are from smaller to larger gatekeeper amino acids ([@bib61]; [@bib6]), while our mutation is between similarly sized but chemically distinct amino acids (glutamine to methionine). Therefore, this mechanism may not be at play. It is also quite possible that our MD simulations are too short to capture changes in the R-spine.

Previous MD simulations have shown changes in angles between the N- and C-terminal domains in gatekeeper mutants of ERK2. This domain closure is a key step in kinase activation ([@bib7]). Therefore, we studied domain closure by calculating the angle between the C and E helices ([Figure 5F](#fig5){ref-type="fig"}). We found a wider distribution of angles in the ERK2-ins55N and ERK2-ins55N-Q103M mutants compared to the WT, suggesting an increase in inter-domain flexibility. However, a true understanding of the relevance of our mutations to domain closure will require much longer simulations as NMR measurements have shown that these motions occur on the millisecond timescale ([@bib66]).

We next took an unbiased approach to identify contacts that were gained or lost by determining a differential contact map between the mutant and wild type kinases for all residue pairs ([Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). In all three mutant simulations, we observed contact changes compared to WT along the activation lip that includes the phosphorylation sites (T183 and Y185). Furthermore, in ERK2-Q103M and ERK2-ins55N-Q103M double mutant simulations, we also observed changes in contacts between the L16 loop (Res.310--336) and αE (Res. 121--141) regions. Additionally, in simulations with the ß3-αC loop insertion mutant (ERK2-ins55N) and the ERK2-double mutant (ERK2-ins55N-Q103M) we observed contact changes between the ß3-αC loop and glycine-rich loop regions (Res. 30--35). We visualized residues that undergo large contact changes on the ERK2 structure ([Figure 5---figure supplement 4D--F](#fig5s4){ref-type="fig"}). This analysis indicated that these changes are mostly in the activation lip and in regions close to mutation sites in the N-lobe. These results are consistent with the changes in RMSF observed above, and additionally implicate changes in activation loop dynamics as a potential mechanism for increased autoactivation.

To gain a deeper understanding of the dynamical impacts of mutations, we built Markov state models (MSMs) from a set of 125 highly informative inter-residue distances (see Materials and methods). MSMs help integrate information from multiple simulations to reveal the system's kinetically distinct clusters of conformations, which are referred to as macrostates ([@bib18]; [@bib52]). We used MSMs to determine which macrostate populations can be perturbed by mutations. We first built MSMs for ERK2-WT and Q103M systems ([Figure 5---figure supplement 5](#fig5s5){ref-type="fig"}) and identified three macrostates. We found that the Q103M mutation increased the populations of macrostates A and C, which had high contact disruption along the activation segment. Macrostate A had the highest overall contact disruption among the three states, and to a lesser extent macrostate C showed a pattern of changes in the activation segment similar to macrostate A, but also had increased disruptions along the L16 loop. We then identified four-state MSMs for the ß3-αC loop insertion and double mutant systems (ERK2-ins55N and ERK2-ins55N + Q103M) ([Figure 5---figure supplement 6](#fig5s6){ref-type="fig"}). Comparing the double mutant MSM to ins55N, we found an increase in the population of macrostate D in the ins55N mutant, which had very little change along the L16 loop but featured an alternative, 'open', conformation of the ß3-αC loop. These MSMs present a vivid picture of the structural changes caused by evolutionary mutations and further implicate increased flexibility in the activation segment as a potential mechanism for increased activity of mutants.

Finally, we compared our simulation data to a previously proposed mechanism ([@bib23]) where gatekeeper mutations were shown to control the accessibility of conformations able to autophosphorylate the activation lip. In all systems, we found a low population of conformations (up to 1.7%) where the Y185 of the 'TxY' motif is hydrogen bonded to the active site D147, an interaction required for autophosphorylation. A large displacement of the Y185, which resides in a hydrophobic pocket, 8.3 Å away from D147 in the crystal structure, is required to achieve this contact. We found these conformations sampled in many of our trajectories (e.g. 325 out of the 1,000 WT trajectories). Unexpectedly, the frequency of these conformations is the highest in WT (1.7%) and decreases for the mutants (0.9% for 55N, 0.4% for Q103M, and 0.2% for 55N-Q103M) ([Figure 5G](#fig5){ref-type="fig"}, which shows only D147-Y185 distances of \<4 Å). The top 100 conformations from the ERK2-WT system with the smallest D147-Y185 distance are shown in [Figure 5H](#fig5){ref-type="fig"}. While demonstrating the structural feasibility of autophosphorylation, these results don't implicate increased contact frequencies between D147 and Y185 as the mechanism for increased autophosphorylation in our case. We note that our simulations do not include ATP, which could affect these conformational equilibria. We examined additional contacts proposed ([@bib23]) to influence the stability of the activation lip: V186-L168, T188-D147 and T188-K149. Of these, only V186-L168 showed significant differences in the distributions of the distances in mutants compared to WT ([Figure 5---figure supplement 3G](#fig5s3){ref-type="fig"}). Consistent with the unexpected decreased frequency of conformations with the Y185 rearranged for hydrogen bonding with D147 in our mutants, the population of conformations with the V186-L168 contact perturbed is highest in WT (42%) and decreases for the mutants (24% for 55N, 29% for Q103M, 22% for 55N-Q103M). In light of these results and the earlier observation of contact changes along the activation lip compared to WT, we sought to examine those changes in more detail. We hypothesized that contact changes to Y185 would be a part of any true autophosphorylating conformations. We therefore specifically examined residues that have large changes in contact frequencies with Y185 ([Figure 5---figure supplement 7](#fig5s7){ref-type="fig"}). For all three mutants, the same seven residues had absolute mean contact changes larger than 0.05: L168, R192, I196, K201, G202, I207, and Y231. Of those, I207 and Y231 lost contacts with Y185 in all mutants, and R192 gained contacts in all mutants. We hypothesize that these residues might tune the rate of the autophosphorylation. It will be interesting to experimentally test these ideas in the future.

While these MD simulations were not long enough to observe the full transition to an active kinase conformation ([@bib27]), they pave the way for future adaptive and enhanced sampling efforts, and offer hypotheses for further mutations to test experimentally. For now, our MD data primarily support the hypothesis that evolutionary mutations tune the contact frequencies of catalytic residues in the kinase active site. It is likely that additional mechanisms will be important at longer timescales, which warrant further investigations.

Reversal of evolutionary regulatory mutations leads to MEK independent ERK activity in vivo {#s2-10}
-------------------------------------------------------------------------------------------

Next, we sought to determine whether the evolutionary insertion mutation led to higher ERK1 activity in vivo. We generated lentivirus encoding ERK1-WT or ERK1-ins74N and transduced NIH 3T3 cells with these two alleles. We used an ERK-KTR reporter ([@bib55]), as our reporter for ERK kinase activity ([Figure 6A](#fig6){ref-type="fig"}). This reporter contains an ERK docking site and phosphoacceptor sites within nuclear localization and export sites. The reporter is designed such that it is localized in the nucleus when unphosphorylated and then translocates to the cytosol when phosphorylated by ERK. Before imaging, cells were pretreated with the MEK inhibitor Trametinib to prevent activation by endogenous mechanisms. When we performed time lapse imaging of cells to observe the localization of the ERK1-KTR reporter, we found that the ERK-KTR reporter was mainly localized in the nucleus in ERK1-WT cells, and only a small percentage of cells indicated any ERK activity ([Figure 6B and C](#fig6){ref-type="fig"}). This confirms that WT-ERK activity was low after inhibition of MEK by Trametinib. In contrast, cells expressing ERK1-ins74N had significantly more ERK-KTR in the cytoplasm. This result suggests that the evolutionary mutation led to MEK-independent ERK1 activity in vivo.

![Reversion of ERK regulatory mutations to the inferred ancestral state leads to MEK independent activity in vivo.\
(**A**) Schematic of the Kinase Translocation Reporter (KTR): phosphorylation of the reporter by ERK1/2 leads to inactivation of a nuclear localization signal (NLS) and activation of a nuclear export signal (NES), leading to nuclear export. Conversely, in cells with low ERK1/2 activity, the NLS is active and NES inactive, therefore the reporter is localized to the nucleus. (**B**) 3T3 cells expressing ERK1 (indicated by coexpression of DsRED with an IRES, after the ERK1 ORF) and the ERK-KTR (green) were treated with 1 μM MEK inhibitor (Trametinib) and grown without FBS. (**C**) Quantification of ERK-KTR localization after 12--14 hr Trametinib treatment and FBS deprivation. The fraction of cells in which the majority of ERK-KTR localizes to the nucleus or cytosol is plotted. Statistical comparisons are by Student's t-test, **^\*\*^**p\<0.01. Error bars indicate ± SD, n = 3, biological replicates (40--50 cells per replicate). (**D**) Quantification of western blot to assess phosphorylation of the ERK TEY, normalized to the ppERK1 fraction in WT ERK1. Protein was extracted after 12--14 hr Trametinib treatment and FBS deprivation.](elife-38805-fig6){#fig6}

We also analyzed the phosphorylation level of the two ERK variants in vivo, by western blot using an antibody specific to phosphorylated ERK. NIH 3T3 cells transduced with both wildtype and mutant ERK were treated with Trametinib. After treatment, proteins were extracted for western blot. The western blot result showed that the phosphorylation level of 'TEY' motif in wild type ERK1 was very low after treatment with Trametinib, while the cells expressing ERK1-ins74N exhibited robust phosphorylation ([Figure 6D](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). These results are consistent with the KTR reporter results, and together show that reversal of the evolutionary insertion mutation led to a decreased dependence on the upstream activating kinase MEK for ERK activity in vivo.

Discussion {#s3}
==========

Regulatory evolution in the MAP kinase group {#s3-1}
--------------------------------------------

Over the past several decades biochemical, genetic and structural studies have provided deep insights into the regulation of kinases. However, the mechanisms by which this diverse array of regulatory mechanisms evolved from a common ancestor remain poorly understood. In this study, we analyzed the regulatory evolution of the ERK kinases that lie within the CMGC group. Ancestral reconstruction revealed that the ability of these kinases to autophosphorylate at their activation loop sharply decreased at the split between the ERK5 and ERK1-2 kinase subfamilies. While the basal activity of the ERK5 subfamily remained relatively high, the ERK1-2 kinase subfamily became strongly dependent on the upstream activating kinase MEK. We identified two mutations that together account for most of the difference between modern ERK1-2 and ERK5. Strikingly, reversal of these evolutionary mutations in modern ERK1 led to high kinase activity and autophosphorylation independent of the upstream activating kinase MEK ([Figure 4](#fig4){ref-type="fig"}).

Mutations in the β3-αC loop are cancer alleles in other kinase families {#s3-2}
-----------------------------------------------------------------------

It has recently been discovered that changes in the β3-αC loop length of BRAF, EGFR, and HER2, none of which are in the CMGC group of kinases, also led to activation of these kinases ([@bib26]). In these cases, the activating mutations shorten the loop rather than lengthen it. In these cases, the shortened loop may pull in the αC helix favoring the 'αC in' conformation. It is interesting that ERK has the opposite behavior. What is generally clear is that the length of the β3-αC loop is a crucial determinant of basal kinase activity.

In previous studies on the evolution of specificity within the CMGC kinase group, we found that an inferred ancestral DFG +1 mutation was also sampled in cancer mutations throughout the kinome ([@bib30]), therefore it is possible that our evolutionary studies within the CMGC group of kinases may be more generally reflected throughout the kinome. The decreasing confidence in reconstructions with evolutionary distance makes it impossible to reconstruct an ur-kinase but features of this progenitor are certain to be retained across every kinase group. Thus, we speculate that β3-αC loop length was has been a critical modulator of basal kinase activity throughout kinase evolution.

Why, then, is ERK not a major oncogene? Oncogenic activation mutations in upstream kinases BRAF, MEK, EGFR and HER2 are frequently observed in cancer. Indeed, the Ras/RAF/MEK/ERK pathway is one of the most important signaling axes in oncogenesis. One possibility is that the upstream regulators have multiple targets in addition to ERK, and indeed this is certainly the case for Ras. Another intriguing possibility is that the dynamical properties of ERK signaling are crucial for its role in oncogenesis. ERK is not simply an ON/OFF switch, but rather oscillates or adapts in various contexts ([@bib3]). It will be interesting to leverage our mutants and investigate more recent inferred ancestral states that may have distinct dynamical properties to investigate this latter possibility.

Evolutionary mutations synergize {#s3-3}
--------------------------------

We found that the evolutionary changes that place ERKs 1 and 2 under stringent regulation synergize in their effects. One change, a polar substitution in the 'gatekeeper' residue of the active site has been previously described as an activating mutation ([@bib23]; [@bib6]). Evolution at the gatekeeper after AncERK1-5 proceeded along two divergent paths. The permissive methionine residue was retained along the branch that led to the modern ERK5 family, which also has high rates of autophosphorylation. The acquisition of a large C-terminal domain is thought to be an alternative source of regulation for ERK5 ([@bib14]). In ERK1-2 the gatekeeper was shifted to glutamine, a more restrictive state for autoactivation.

The second evolutionary change that we implicated in the decrease in autophosphorylation at the transition to AncERK1-2, a change in loop length between the β3 strand and αC helix, has not been reported before. The inferred deeper CMGC ancestors and the modern ERK kinases that have higher basal activity, ERK5 and ERK7, all had one extra amino acid in this loop ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). The reversal of the shortening of this loop in AncERK1-2 and in modern ERK1 and ERK2 drastically increased kinase activity ([Figure 3A](#fig3){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Each of these evolutionary changes confers an order of magnitude change in basal activity, and when combined, these two mutations increase the basal activity of ERKs 1 and 2 by more than two orders of magnitude. This additive, relatively independent effect of the two mutations may have provided evolutionary pathways that could have both conferred a selective advantage to intermediates and allowed for evolution towards a tightly controlled system without major fitness barriers.

Structural dynamics and control of kinase activity {#s3-4}
--------------------------------------------------

Our molecular dynamics simulations indicated that reversal of the inferred evolutionary mutations (i.e. reversion to a more active inferred ancestral state) had two clear effects on the rapid timescale (ns - μs) dynamics of ERK2. First, there was increased flexibility in the glycine rich loop and loop 16 ([Figure 5A--C](#fig5){ref-type="fig"}). The reorganization of loop 16 is important in the domain closure of kinases, which is an intrinsic part of the conformational shift to an active state. This observation is consistent with earlier MD simulations that showed that gatekeeper mutations can increase domain closure ([@bib7]). However, our simulations are too short to directly observe domain closure. Markov State Models also suggested increased dynamics of the activation segment. The most compelling hypothesis suggested by our MD simulations was that the active site is more likely to attain a productive conformation in mutants, as indicated by more frequent formation of the K52-E69 salt-bridge in mutants than wild type ([Figure 5D](#fig5){ref-type="fig"}).

Robust evolution in the CMGC kinase group {#s3-5}
-----------------------------------------

Previous ancestral reconstruction studies have highlighted the importance of epistasis in the diversification of function. For example, changes in the specificity of hormone-receptor ligand binding domains required stabilizing mutations ([@bib63]) prior to the advent of mutations that alter specificity, and the acquisition of novel mutations after acquisition of a new function made it difficult to revert to the inferred ancestral state ([@bib13]). In our previous study on the evolution of kinase specificity, we found no requirement for stabilizing mutations -- robust activity was maintained as specificity changed. In the current study, we find that the reversion of a single or double evolutionary mutation is also well tolerated and that we can revert modern ERK1 and ERK2 to an inferred ancestral state of high basal activity - there is not a strong \"evolutionary ratchet\". Together these observations suggest that kinases are quite tolerant of mutations, which perhaps explains their frequent dysregulation in diseases like cancer. The diversification of kinase specificity and regulation may also be underpinned by this surprising tolerance of a dynamic domain to mutations that drive neofunctionalization. Perhaps this 'evolvability' explains the prevalence of kinases as regulatory enzymes in *Eukaryotes*.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------
  Reagent type          Designation                  Source           Identifiers       Additional\
                                                                                        information
  --------------------- ---------------------------- ---------------- ----------------- --------------------------------------------
  Cell line             NIH3T3                       ATCC             CRL1658           

  Antibody              anti-ERK                     Santa Cruz Bio   SC154             WB:1:200

  Antibody              anti-p-ERK                   Santa Cruz Bio   SC7383            WB:1:200

  Recombinant DNA       His AncCM                    This paper       pLH1347           for purification from *E. coli*

  Recombinant DNA       His AncMAPK                  This paper       pLH1348           for purification from *E. coli*

  Recombinant DNA       His AncJPE                   This paper       pLH1349           for purification from *E. coli*

  Recombinant DNA       His AncERK                   This paper       pLH1350           for purification from *E. coli*

  Recombinant DNA       His AncERK1-5                This paper       pLH1571           for purification from *E. coli*

  Recombinant DNA       His AncERK1-2                This paper       pLH1572           for purification from *E. coli*

  Recombinant DNA       His ERK1                     This paper       pLH1573           for purification from *E. coli*

  Recombinant DNA       His MEK                      This paper       pLH1574           for purification from *E. coli*

  Recombinant DNA       MEK (without His tag)        This paper       pLH1575           for purification from *E. coli*

  Recombinant DNA       His ERK1-R84T                This paper       pLH1576           for purification from *E. coli*

  Recombinant DNA       His Elk1-GFP-FRB             This paper       pLH1577           for purification from *E. coli*

  Recombinant DNA       His AncCDK.MAPK-AxF          This paper       pLH1578           for purification from *E. coli*

  Recombinant DNA       His AncJPE-AxF               This paper       pLH1579           for purification from *E. coli*

  Recombinant DNA       His AncERK-AxF               This paper       pLH1580           for purification from *E. coli*

  Recombinant DNA       His AncERK1-2-Q89M           This paper       pLH1581           for purification from *E. coli*

  Recombinant DNA       His AncERK1-2-ins44R         This paper       pLH1582           for purification from *E. coli*

  Recombinant DNA       His AncERK1-2-ins44R-Q89M    This paper       pLH1583           for purification from *E. coli*

  Recombinant DNA       His Alt1.AncERK1-5           This paper       pLH1584           for purification from *E. coli*

  Recombinant DNA       His Alt2.AncERK1-5           This paper       pLH1585           for purification from *E. coli*

  Recombinant DNA       His Alt1.AncERK1-2           This paper       pLH1586           for purification from *E. coli*

  Recombinant DNA       His Chimera 1                This paper       pLH1587           for purification from *E. coli*

  Recombinant DNA       His Chimera 2                This paper       pLH1588           for purification from *E. coli*

  Recombinant DNA       His Chimera 3                This paper       pLH1589           for purification from *E. coli*

  Recombinant DNA       His Chimera 4                This paper       pLH1590           for purification from *E. coli*

  Recombinant DNA       His Chimera 5                This paper       pLH1591           for purification\
                                                                                        from *E. coli*

  Recombinant DNA       His AncERK1-5-del46R         This paper       pLH1592           for purification\
                                                                                        from *E. coli*

  Recombinant DNA       His AncERK1-5-M90Q           This paper       pLH1593           for purification from *E. coli*

  Recombinant DNA       His AncERK1-5-del46R-M90Q    This paper       pLH1594           for purification\
                                                                                        from *E. coli*

  Recombinant DNA       His ERK1-Q122M               This paper       pLH1595           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N              This paper       pLH1596           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-Q122M        This paper       pLH1597           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N AxY          This paper       pLH1598           for purification\
                                                                                        from *E. coli*

  Recombinant DNA       His ERK1-ins74N TxF          This paper       pLH1599           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N AxF          This paper       pLH1600           for purification from *E. coli*

  Recombinant DNA       GST-ERK1-ins74N              This paper       pLH1601           for purification from *E. coli*

  Recombinant DNA       GST-ERK1- ins74N KD          This paper       pLH1602           for purification\
                                                                                        from *E. coli*

  Recombinant DNA       His ERK1-ins74W              This paper       pLH1603           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74v              This paper       pLH1604           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74a              This paper       pLH1605           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74G              This paper       pLH1606           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74Q              This paper       pLH1607           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74S              This paper       pLH1608           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74D              This paper       pLH1609           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delK72       This paper       pLH1610           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delI73       This paper       pLH1611           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delS74       This paper       pLH1612           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delP75       This paper       pLH1613           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delF76       This paper       pLH1614           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delE77       This paper       pLH1615           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delH78       This paper       pLH1616           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N-delQ79       This paper       pLH1617           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins72N              This paper       pLH1618           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins73N              This paper       pLH1619           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins74N              This paper       pLH1620           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins75N              This paper       pLH1621           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins76N              This paper       pLH1622           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins77N              This paper       pLH1623           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins78N              This paper       pLH1624           for purification from *E. coli*

  Recombinant DNA       His ERK1-ins79N              This paper       pLH1625           for purification from *E. coli*

  Recombinant DNA       ERK KTR                      [@bib55]         Addgene \#59150   Monitoring ERK activity in mammalian cells

  Recombinant DNA       ERK1 wt DsRED                This paper       pLH1626           for expresson in mammalian cells

  Recombinant DNA       ERK1-ins74N DsRED            This paper       pLH1627           for expresson in mammalian cells

  Recombinant DNA       ERK1 wt overexpression       This paper       pLH1628           for expresson in mammalian cells

  Recombinant DNA       ERK1-ins74N overexpression   This paper       pLH1629           for expresson in mammalian cells

  Recombinant protein   MBP                          EMD Millipore    13--104           kinase substrate

  Recombinant DNA       His ERK2                     This paper       pLH1630           for purification from *E. coli*

  Recombinant DNA       His ERK2-ins55N              This paper       pLH1631           for purification from *E. coli*

  Recombinant DNA       His ERK2-Q103M               This paper       pLH1632           for purification from *E. coli*

  Recombinant DNA       His ERK2-ins55N-Q103M        This paper       pLH1633           for purification from *E. coli*
  ----------------------------------------------------------------------------------------------------------------------------------

Protein Expression and Plasmid Construction {#s4-1}
-------------------------------------------

pET28b vectors were used for bacterial expression. Open Reading Frames (ORFs) of the Erk proteins were fused N terminally to the 6X histidine tag for purification. Glutathione S Transferase (GST) was inserted between the 6X His-tag and the Erk ORF in order to increase protein molecular weight. For site-directed and domain-swapping mutagenesis, primers containing the point mutation sites or domain junction sites for chimera protein were designed. The PCR fragments and the vectors were assembled according to the manufacturer's instructions using Gibson Assembly Master Mix kit from New England Biolabs (NEB). All the constructs were verified via DNA sequencing.

Mammalian cell culture {#s4-2}
----------------------

NIH3T3 ATCC CRL1658 Cell lines were verified using short tandem repeat DNA profiling (STR Profiling) by PCR amplification of 9 STR loci plus Amelogeninusing Promega GenePrint 10 System, Fragment Analysis with ABI 3730XL DNA Analyzer, comprehensive data analysis with ABI Genemapper software and final verification using supplier databases including ATCC and DSMZ. Cell lines were checked and tested negative for mycoplasma infection. Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS), penicillin, and streptomycin. The cells were incubated at 37°C and 5% CO2. Transfections of HEK293T cells were performed using TransIT-293 Transfection Reagent (Mirus), according to the manufacturer's instructions. Viral supernatants were collected 48--72 hr following transfection of 293 T cells. After virus infection, NIH3T3 cells were selected with 1--2 μg/ml puromycin. For western blot, cells were first washed three times with PBS, then incubated in medium with no serum and treated with 2 µM Trametinib. After 12 hr, cells were lysed by addition of SDS loading buffer containing 20% glycerol, 4% SDS, 0.1 M Tris (pH 6.8), 0.2 M dithiothreitol (DTT), and phenol blue dye, followed by boiling at 100°C for 10 min.

Protein purification {#s4-3}
--------------------

Protein purification from *E. coli* cells was performed as previously described ([@bib30]). Briefly, proteins were expressed in Rosetta2 DE3 competent cells by induction with 100 μM IPTG for 18 hr at 16°C. Bacterial culture were collected and centrifugated at 4000 rpm for 20 min at 4°C. The cell pellet was resuspended in cold lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole pH7.6, 1 mM PMSF). After sonication, the lysate was centrifuged at 12000 rpm for 20 min at 4°C. The supernatant was mixed with magnetic Ni-NTA beads (Biotool) and incubated for 1 hr at 4°C. The bound beads were collected and rinsed 3 × with wash buffer containing (50 mM NaH2PO4, 300 mM NaCl, 40 mM imidazole pH7.6). The bound proteins were eluted with elution buffer (50 mM NaH2PO4, 300 mM NaCl, 500 mM imidazole pH7.6). The elution was dialyzed into storage buffer (150 mM NaCl, 50 mM HEPES pH8, 1 mM DTT, 10% glycerol) using Zeba Spin Desalting Columns (Thermo scientific), and flash frozen in aliquots with liquid nitrogen and stored at 80°C.

Western blots {#s4-4}
-------------

For recombinant proteins, 200 ng protein were mixed with SDS loading buffer and boiled at 100°C for 10 min. For mammalian cells, the protein lysates were prepared by removing the medium, washing with PBS, and adding SDS buffer directly to the plate. Cell lysates were collected and boiled for 10 min. The samples were separated on 4--12% Bis-Tris gels (ThermoFisher Scientific) and transferred to a nitrocellulose membrane. Membranes were probed with anti-ERK (SC154, Santa Cruz Biotechnology) or anti-p-ERK (SC7383, Santa Cruz Biotechnology).

In vitro kinase assays {#s4-5}
----------------------

0.05 µg purified recombinant 6x His-tagged Erk protein was used in a total volume of 10 µl (approximately 0.1 µM). Final reaction conditions were 20 mM Hepes, pH 7.5, 10 mM MgCl~2~, 50 mM NaCl, 0.75 µg/µl myelin basic protein (MBP), 100 µM ATP, and 0.05 µCi of \[γ-^32^P\]ATP. The kinase reactions proceeded for 30 min at room temperature and were terminated by addition of 6 µl 5x SDS loading buffer (10% SDS, 0.5 M DTT, 50% glycerol, 0.25% Bromophenol blue). All samples were separated on 4--12% Bis-Tris gels (ThermoFisher Scientific). The gel was dried and exposed to a phosphor screen. Phosphor screens were analyzed with a Typhoon 9500 scanner (GE) using ImageQuant software (GE). Michaelis--Menten curves were generated in a similar manner, except the buffer contained 300 µM ATP and varying concentration of MBP. Data were fit by nonlinear regression to the Michaelis--Menten model V~0~ = \[ERK\]\* k~cat~ \*\[S\]/K~M~+\[S\] using Prism 8 (GraphPad software) and the fit was used to determine values for k~cat~ and K~M~.

Autophosphorylation assay {#s4-6}
-------------------------

0.1 µg purified recombinant 6x His-tagged Erk protein (approximately 0.2 µM) was incubated in kinase reaction buffer (20 mM Hepes, pH 7.5, 10 mM MgCl~2~, 50 mM NaCl, 25 µM ATP, and 0.05 µCi of \[γ-^32^P\]ATP) without substrate. The autophosphorylation reactions proceeded for 30 min at room temperature and were terminated by addition of 6 µl 5x SDS loading buffer. All samples were separated on 4--12% Bis-Tris gel (ThermoFisher Scientific). The gel was dried and exposed to phosphor screen. Phosphor screens were analyzed with a Typhoon 9500 scanner. Autophosphorylation of ERK1 ins74N was measured at 5, 10, 15, and 20 min, as previously desctibed ([@bib23]). Reactions were terminated, and proteins were seperated by SDS/PAGE, and phosphate incorporation was quantified by using ImageQuant software (GE).

Liquid chromatography MS {#s4-7}
------------------------

### Sample preparation for mass spectrometry analysis {#s4-7-1}

50 µg of each purified protein was reduced using dithiothreitol (2 μl of 0.2 M) for 1 hr at 55°C. The reduced cysteines were subsequently alkylated with iodoacetamide (2 μl of 0.5 M) for 45 min in the dark at room temperature. The protein samples were digested with trypsin (Promega) at a 100:1 (protein:enzyme) ratio overnight at room temperature. The pH of the digested protein lysates were lowered to pH \< 3 using trifluoroacetic acid (TFA). The digested lysates were desalted using C18 solid-phase extraction (Sep-Pak, Waters). 40% acetonitrile (ACN) in 0.5% acetic acid followed by 80% acetonitrile (ACN) in 0.5% acetic acid was used to elute the desalted peptides. The peptide eluate was concentrated in the SpeedVac and stored at −80 C.

### Mass spectrometry analysis {#s4-7-2}

1 µg of each sample was loaded onto a trap column (Acclaim PepMap 100 pre-column, 75 μm × 2 cm, C18, 3 μm, 100 Å, Thermo Scientific) connected to an analytical column (EASY-Spray column, 50 m × 75 μm ID, PepMap RSLC C18, 2 μm, 100 Å, Thermo Scientific) using the autosampler of an Easy nLC 1000 (Thermo Scientific) with solvent A consisting of 2% acetonitrile in 0.5% acetic acid and solvent B consisting of 80% acetonitrile in 0.5% acetic acid. The peptides were eluted into either an Orbitrap QExactive (Thermo Fisher Scientific) or Orbitrap QExactive HF-X mass spectrometer (Thermo Fisher Scientific) respectively, using the following gradient: 5--35% in 60 min, 36--45% in 10 min, followed by 45--100% in 10 min. Protein samples for Erk1 and Erk1-ins74N were acquired on an Orbitrap QExactive mass spectrometer, with full MS spectra recorded at a resolution of 70,000, an AGC target of 1e6, with a maximum ion time of 120 ms, and a scan range from 400 to 1500 m/z. Following each full MS scan, twenty data-dependent MS/MS spectra were acquired. The MS/MS spectra were collected with a resolution of 17,500 an AGC target of 5e4, maximum ion time of 120 ms, one microscan, 2 m/z isolation window, fixed first mass of 150 m/z, dynamic exclusion of 30 s, and normalized collision energy (NCE) of 27. Protein samples for AncCDK.MAPK, AncMAPK, AncJPE, AncERK, AncERK1-5 and AncERK1-2 were acquired on the QExactive HF-X using data dependent acquisition mode (DDA) or parallel reaction monitoring mode (PRM). In both cases, high resolution full MS spectra were recorded with a resolution of 45,000, an AGC target of 3e6, a maximum ion time of 45 ms, and a scan range from 400 to 1500/z. For samples acquired using DDA mode, MS/MS spectra were collected with a resolution of 15,000 an AGC target of 1E5, maximum ion time of 120 ms, one microscan, 2 m/z isolation window, fixed first mass of 150 m/z, dynamic exclusion of 30 s, and normalized collision energy (NCE) of 27. For samples acquired using PRM mode, PRM scans were acquired for the peptides of interest following each full MS scan. The MS/MS spectra were collected with a resolution of 15,000 an AGC target of 2E5, maximum ion time of 200 ms, one microscan, 2 m/z isolation window, fixed first mass of 150 m/z, dynamic exclusion of 30 s, and normalized collision energy (NCE) of 27.

### Data processing {#s4-7-3}

For all samples, the MS/MS spectra were searched against a given protein sequence of interest using Byonic (Protein Metrics Inc, San Carlos, CA)([@bib10]). The mass tolerance was set to 10ppm for MS1 and 0.02 Da for MS2 searches. False discovery rate (FDR) of 1% was applied on the protein level. The Byonic search included fixed modification of carbamidomethylation on cysteine and variable modifications of oxidation on methionine, and phosphorylation at serine, threonine and tyrosine residues. The spectra of the peptides of interest were manually verified to localize the phosphorylation site. For relative quantification of the phosphorylation sites the semi-automatic program Byologic (Protein Metrics Inc, San Carlos, CA) was used to obtain the area under the curve (AUC) for the extracted ion chromatogram of each peptide isoform. The AUC was manually verified and adjusted if appropriate for each isoform. The percent phosphorylation was obtained by dividing the isoform AUC by the total AUC for the peptide. The data can be found in the supplementary data table MS-source.

Imaging and image analysis {#s4-8}
--------------------------

To assess the activity of Erk in mammalian cells, ERK-KTR was expressed from the CMV promoter in vector pLentiCMV (Addgene \#59150). ERK kinase was expressed along with a dsRed reporter expressed from an IRES. Cells were seeded on six well plates one day before imaging. At 30% confluency, media was changed to media without FBS and containing Trametinib (final concentration 2 µM) 2 hr prior to imaging. Cells were imaged with a Nikon Eclipse Ti fluorescence microscope. All imaging was carried out at constant conditions of 37°C, 5% CO2, and constant humidity. The subcellular distribution of the KTR reporter was analyzed with Image J. Cells expressing both Kinase and KTR reporter were used for analysis.

MD simulations {#s4-9}
--------------

To perform MD simulations of ERK2-ins55N, ERK2-Q103M (gatekeeper mutation), and ERK2-ins55N + Q103M (double mutant) mutants, we used the unphosphorylated ERK2 (PDB ID: 1ERK). We introduced the insertion to ERK2 (55N) using Discovery Studio 4.5 software ([@bib11]), and then modeled the loops using Modloop web server ([@bib24]). We mutated the gatekeeper residue 103(Q \> M) in ERK2 and ERK2-ins55N using the VMD Mutator tool to obtain the structures.

We next solvated the proteins with water in cubic boxes with at least 1 nm padding on all sides of the protein and neutralized with a minimal amount of NaCl using OpenMM 7.2 ([@bib22]). We recorded the largest number of water and ion molecules added to any of the proteins (20,959 molecules) and solvated again in cubic boxes using that number of molecules. This resulted in systems of between 68,670 and 68,684 atoms. We then energy minimized and equilibrated the systems for 10 ns in the NpT (p=1 atm, T = 300 K) ensemble using the OpenMM Langevin integrator with a two fs timestep and a 20 ps^−1^ collision rate. We controlled the pressure by a Monte Carlo molecular-scaling barostat with an update interval of 50 steps. We treated non-bonded interactions with the Particle Mesh Ewald ([@bib19]) method using a real-space cutoff of 0.9 nm and relative error tolerance of 0.0005, with grid spacing selected automatically. We constrained all covalent bonds involving hydrogen and did not remove the center of mass motion since this was unnecessary given the use of a Langevin integrator.

Next, we packaged these simulations as seeds with OpenMM 6.3.1 ([@bib21]) to initiate massively parallel distributed MD simulations (production simulations) on Folding\@home ([@bib58]). For all simulations, we used the parameter files included in the OpenMM 7.2 distribution ([@bib22]) for the Amber ff99SB-ILDN force field ([@bib42]) and the TIP3P rigid water model ([@bib37]). For NaCl, we used the adapted Aqvist (Na^+^) ([@bib5]) and Smith and Dang (Cl^-^) ([@bib59]) parameters. For production simulations, we used the same Langevin integrator as the NpT equilibration described above, except that to provide realistic heat exchange with a thermal bath while minimally perturbing dynamics, we set the Langevin collision rate to one ps^−1^. In total, we generated 1000 independent MD simulations on Folding\@home ([@bib58]) for each system, which totaled 4,000 MD simulations, of which 3999 successfully collected data. We propagated the simulations until a total of at least 500 μs of simulation time for each system had been collected, resulting in the grand total of 2.05 ms of simulation time and 4,104,841 frames (see [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"} for trajectory length distribution histogram). The average trajectory length was 513 ns. This amount of simulation time corresponded to \~240 GPU-years on an NVIDIA GeForce GTX 980 processor. To use conformational snapshots (frames) in subsequent analyses, we stored them at intervals of 0.5 ns/frame.

### Calculation of RMSFs {#s4-9-1}

To study the flexibility of the kinase, we calculated root mean square fluctuations (RMSFs) for each trajectory using NumPy ([@bib51]). These calculations measure the amplitude of residue Cα atom motions during MD simulations. To allow for further relaxation from the initial equilibrated structures, we did not use the first 50 ns of each trajectory. We used Seaborn (mwaskom/seaborn) with Matplotlib ([@bib31]) to plot the RMSF means over all trajectories, 95% confidence intervals of the means, and differences between the wild type and mutant ([Figure 5A--C](#fig5){ref-type="fig"}).

### Calculation of domain closure {#s4-9-2}

To study the motion between N and C domains we calculated the domain closure as the angle between the helices C and E. We did a least squares fit of a vector (\'helix axis\') for each helix to the positions of the carbonyl C and O atoms, and then recorded the angle between those vectors ([Figure 5G](#fig5){ref-type="fig"}). To allow for further relaxation from the initial equilibrated structures, we did not use the first 50 ns of each trajectory.

### Calculation of residue-residue distances {#s4-9-3}

To understand the mutation-induced changes in the interactions between residues that are important for activity and/or along the regulatory and catalytic spines, we calculated the closest heavy atom residue-residue distances using all frames using MDTraj ([@bib44]) for each trajectory. Again, we did not use the first 50 ns of each trajectory. Specifically, in ERK2, we calculated the residue-residue distances between: 1) Catalytic sites (E69-F166, K52-E69, D165-K52) 2) Regulatory spine (I84-L73, L73-F166, F166-H145, H145-D208) and 3) Catalytic spine (V37-A50, A50-L154, L153-L155, L153-M106, L155-M106, M106-I215, I215-M219). To determine whether the probability distributions of the distances were significantly altered due to mutation, we performed the Kolmogorov-Smirnov (K-S) test with SciPy ([@bib36]) using the K-S statistic cutoff of 0.1. We plot the probability distributions of distances where at least one of the mutants showed difference from that of the WT using Seaborn with Matplotlib ([@bib31]) ([Figure 5A--F](#fig5){ref-type="fig"}). Analogically, to understand the mutation-induced changes in the interactions between residues proposed ([@bib23]) to be important in controlling accessibility of conformations able to autophosphorylate the activation lip, we calculated the following closest heavy atom residue-residue distances: V186-L168, T188-D147, T188-K149, Y185-D147.

### Calculation of contact maps {#s4-9-4}

We calculated the closest heavy atom residue-residue distances for all pairs of residues for each trajectory using MDTraj ([@bib44]), converted to binary contact maps using a contact cutoff of 4 Å, and averaged over all frames of the trajectory using NumPy ([@bib51]). The first 50 ns of each trajectory were not used to allow for further relaxation from the initial equilibrated structures. The contact maps for all trajectories of a given system were averaged. The wild type contact maps were subtracted from the mutant contact maps to generate differential contact maps for further annotation ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).

### Construction of Markov state models (MSMs) {#s4-9-5}

We trained the XGBoost ([@bib17]) gradient boosted decision tree algorithm on the per-trajectory mean binary contacts to classify the origin of a trajectory from the four protein systems. Following an established method ([@bib12]) using an iterative exclusion principle, we trained and cross-validated (2/3 of the dataset were used for training, and 1/3 for testing) the model, then removed the contact feature with the highest importance to classification and repeated the procedure with remaining features. This was continued until the classification accuracy dropped below 90%, resulting in 125 top contact features. The distances corresponding to those contacts were calculated and used as features for Markov state models (MSMs). All modeling was performed using PyEMMA ([@bib57]). First, we commute-mapped ([@bib49]) and reduced the dimensionality of the data using time-lagged independent component analysis (tICA; [@bib53]), keeping 95% of the kinetic variance, resulting in X tICs. The data were then clustered into 100 microstates using k-means, to partition the data into a minimal number of states sufficient for reasonable description of the dynamics, while avoiding overfitting ([@bib33]). There was negligible overlap in state space between WT/Q103M and the insertion containing 55N/55N-Q103M -- the former occupied 30 microstates and the latter occupied 71 microstates, with only one microstate in common, likely to be due to noise. We hence built two separate MSMs -- one for WT and Q103M combined, the other for 55N and 55N-Q103M combined. The MSMs were built from two different systems so that we could find a common definition of macrostates, under the assumption that the Q103M mutation causes changes to the populations of macrostates but not their metastability. We assessed the implied timescales of the MSMs, and found approximate convergence at 100 ns lag time. The top timescales were 0.47 µs and 1.81 µs for the WT/Q103M and 55N/55N-Q103M MSMs, respectively. We sought to coarse-grain the MSMs into less than five macrostates for easy interpretability, and we chose their number so that the sum of population differences between WT and Q103M, or 55N and 55N-Q103M was maximized for best interpretability of differences caused by the mutation. This resulted in 3 and 4 macrostates for the WT/Q103M and 55N/55N-Q103M MSMs, respectively. The coarse graining was performed using PCCA++. The MSMs were validated with Chapman-Kolmogorov (C-K) tests using those macrostate definitions. To calculate the populations of the macrostates in each individual system, four separate MSMs were also built. The choice of the lag time and model fidelity were again evaluated with implied timescales and C-K tests. Finally, the macrostate populations were calculated by weighted sum over microstate populations in each of the four individual MSMs, using the PCCA ++fuzzy memberships of microstates to macrostates from the 2 MSMs built with combined systems as weights. We randomly drew 100 samples from the dataset for each macrostate and calculated their mean contact maps. As a reference, we calculated the average contact map for WT weighted by macrostate populations, and subtracted it from the mutant macrostate contact maps to generate differential contact maps for further annotation ([Figure 5---figure supplements 4](#fig5s4){ref-type="fig"} and [5](#fig5s5){ref-type="fig"}).

### Data and code accessibility {#s4-9-6}

The molecular dynamics simulation data is available via the Open Science Framework at: [https://osf.io/dp4cb/.](https://osf.io/dp4cb/)

The code used to analyze the data is available at [https://github.com/choderalab/ERK-ancestral-materials ([@bib65]; copy archived at](https://github.com/choderalab/ERK-ancestral-materials)<https://github.com/elifesciences-publications/ERK-ancestral-materials>).

Ancestral reconstruction of the ERK1 and ERK2 lineage {#s4-10}
-----------------------------------------------------

We identified orthologs of human ERK1, ERK2, ERK5 and ERK7 using a protein BLAST ([@bib4]) search against the genomes of a diverse set of eukaryotes. The obtained sequences were clustered using CD-HIT ([@bib41]) at 95% identity to collapse closely related kinases into one sequence. These were then reverse blasted against the human ERKs to identify the kinase that they were most closely related to. For the purposes of reconstruction, they were considered to be the ortholog of this kinase. After some manual curation, the final list of 150 sequences was fed into Phylobot ([@bib29]) for ancestral reconstruction with sequences from similarly collected p38 and JNK orthologs used as an outgroup to root the tree.

All primary data can be accessed at the following urls:

InputFasta File:

<http://webdoc.nyumc.org/phylobot/Sang2019_Input_fasta_ERK_resurrection.fasta>

Output Fasta File:

<http://webdoc.nyumc.org/phylobot/>Sang2019_Output_fasta_ERK_ancestors.fasta

SQL Database containing all resurrection data:

<http://webdoc.nyumc.org/phylobot/Sang2019_ERK_ASR.db>

The full reconstruction can be found at:

<http://phylobot.com/350478581/msaprobs.PROTCATLG/ancestors>
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article \"Ancestral resurrection reveals mechanisms of kinase regulatory evolution\" for consideration by *eLife*. Your article has been favorably reviewed by three peer reviewers, and the evaluation has been overseen by John Kuriyan as the Senior Editor and the Reviewing Editor. The following individual involved in review of your submission has agreed to reveal her identity: Dorothee Kern (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

In this paper, Sang et al. use ancestral reconstruction to study the evolution of MAP kinase regulation. The authors analyzed the specificity and activity of several kinases that represent common ancestors of major kinase families within the CMGC group. Interestingly, they found that the dependence on upstream MAPKK phosphorylation occurred at the transition between the common ancestor of the ERK 1/2/5 kinases (AncERK1-5) and the common ancestor of ERK 1/2 (AncERK1-2). Specifically, the authors present convincing data that a two amino acid change late in evolution between the ancestor of ERK5 and ERK1 and 2 toward ERK1-2 caused a large decrease in autophosphorylation rate, and autophosphorylation was replaced by MEK phosphorylation. This is a beautiful result!

Overall, the study is well designed and presented, and the results will be of high interest to investigators studying kinase regulation.

The manuscript builds upon the authors\' previous *eLife* paper, which described the divergence of substrate specificity in related kinases using similar approaches, and thus warrants publication as an *eLife* Research Advance after revision.

Major issues that must be addressed, with additional experiments as necessary:

Although this is broken down into separate points, 1 to 6 below, all of these issues are related to putting the activities of the relevant kinases on a more rigorous footing. We ask that a substantial response be prepared for these questions, but the authors should judge whether particular experiments can be done in a realistic timeframe or not. Note that these questions are important, so a simple response that none of the experiments can be done in a timely fashion will not be deemed a satisfactory response.

1\) The authors use MBP phosphorylation as readout for intrinsic activity, but as in their previous paper, they show that each ancestral kinase has a slightly different substrate specificity. Is it possible that the differences observed for MBP phosphorylation are due to difference in sequence specificity, rather than intrinsic activity?

2\) In this assay, does MEK have any significant activity toward MBP? This should be measured as a control.

3\) The activity measurements done in the paper are endpoint assays of myelin basic protein phosphorylation. For at least the key proteins (ERK1, AncERK1-5, AncERK1-2), the authors should carry out kinetic experiments. This would allow them to determine whether the effects are driven by changes in k~cat~, K~M~, or a combination.

4\) What are the phosphorylation states of each protein prior to the MBP phosphorylation reactions? It would be important to compare the activities of all proteins for the same phosphorylation states (nonphosphorylated versus doubly phosphorylated proteins). The activity data presented in Figure 1B represent the results of different mixtures of non- and phosphorylated kinases according to Figure 2B and C.

For this, the quantification of phosphorylation for all samples need to be measured first, and then activity data collected for clean species (in Figure 2B and C, only a subset of proteins were characterized). Particularly AncERC1-5and AncRC1-2 are missing in respect to analysis of differential phosphorylation rates, the crucial proteins where the switch seem to happen in evolution.

5\) A distinction should be made throughout the manuscript between \"intrinsic activity\" and regulation by activation loop auto-phosphorylation. Differences in \"intrinsic activities\" would ideally be assessed by comparing the enzymatic activities of all kinases in the same phosphorylation states. In other words, how active are each of the unphosphorylated kinases, and how active are those same kinases after activation loop phosphorylation? What the authors are measuring in the beginning of the Results section, and in Figure 1B, appears to be the consequence of a difference in the ability to auto-phosphorylate and thus auto-activate, not necessarily a difference in intrinsic activity.

6\) Related to these points, it would be informative to see raw data (phosphorimages) from the MBP phosphorylation reactions in Figure 1B as a figure supplement, rather than just a normalized quantification of endpoint intensities.

7\) Finally, we ask that the amino acid sequences of all proteins (modern and resurrected) be included in the supplementary materials, and it would be of value to give the number of substitutions in the text. The full tree used for ancestral sequence reconstruction (ASR), including the species, needs to be included for reproducibility for the field. A supplementary figure that shows the probabilities of the nodes, and information of the posterior probabilities for the full sequences is essential to evaluate ASR.

Other important issues that require response:

1\) The authors should avoid language that implies that the ancestral protein sequence is actually known. A sophisticated reader will understand what is meant, but we are concerned that the way that much of the paper is written a strong impression is given that the ancestral sequence is actually synthesized. This is not just a semantic point, because it may turn out that errors in the sequence reconstruction have led to misleading results. We do not consider this point to invalidate the conclusions of this study, but we ask that the language used to describe the \"ancestral\" sequences be changed throughout the manuscript. A few comments, given below, should help explain what we mean.

The method of ancestral sequence reconstruction is a powerful approach to dissect molecular differences between close-related biomolecules. However, the use of the dramatic term \"resurrection\" should be avoided throughout this manuscript, as it implies that we have explicit knowledge of the true protein sequences found in ancestral organisms, which is then \"resurrected\". The more common term, \"reconstruction\", is more appropriate, as it indicates that a sequence model of a plausible ancestral protein is being generated using the best available evidence. An example of a statement that implies that the ancestor is truly known, and that the authors should avoid is the following:

\"As part of this study, we observed that a deep ancestor of this group had relatively high intrinsic activity even in the absence of any activating kinase of or allosteric activators.\"

In the beginning of the main section of the paper, the authors use the following phraseology, which correctly captures the inherent uncertainty in the \"resurrected\" sequences: \"We synthesized the coding sequences for these inferred ancestors\".

2\) The manuscript is focused on the specific late evolution between ERK5 and ERK 1 and 2, and there is no information about the evolution of regulation towards CDKs, MAPKs, *JNK*, p38. Therefore the Introduction, Abstract and title should be modified to reflect the data from this manuscript (for instance: \"Ancestral resurrection reveals mechanism of kinase regulatory evolution of ERK\").

3\) To enlighten the reader about the evolutionary trajectory, key information to add would be how modern ERK5, ERK 7 that branch off the ancestors used in this study are behaving in respect to activities of their nonphosphorylated and phosphorylated activation loop states towards substrates, and their ability to autophosphorylate.

4\) What is the explanation of a much higher activity of AncERK1-2 with the two mutations in the presence of MEK relative to AncERK1-2 in the presence of MEK? Could the authors also include the data for the reverse experiment, AncERK1-5 M89Q 44Rdel, both in the absence and presence of MEK, in Figure 3?

5\) 300 ns trajectories are very short MD simulations, and it is quite unlikely that refolding of the L16 loop coupled to domain closure is on that time scale. NMR data for ERK has suggested that these processes occur on the millisecond time-scale. Thus, the MD simulations are not convincing due to the discrepancy in time scale between the suggested conformational changes and the length of the simulations, and rather weaken the manuscript than strengthen it. The authors should consider carefully what information is contributed by the MD simulations, and then describe that with appropriate cautionary notes. Alternatively, remove the MD simulations from the manuscript.

Should the MD simulations be retained, the authors should clarify what atoms are being used to measure the distances between residues in the analyses of MD simulations. In particular, for salt bridges, as in the one analyzed in Figures 5C, F, it would be most informative to look at distances between terminal or near-terminal atoms of the side chains (e.g. the terminal nitrogen of the lysine sidechain and the δ carbon or one of the oxygens of the glutamate residue).

6\) The figures could be better arranged and assembled, it is hard to jump back and forth between gels and activity figures. Could all data be presented in a quantitative format (activity towards MBP and autophosphorylation)?

7\) The authors should include an LC/MS quantification of TEY motif phosphorylation for AncERK1-5 and AncERK1-2 (i.e., a similar analysis as was done in Figure 2C).

8\) Figure 4E does not conclusively establish the mechanism of autophosphorylation; His6-ERK1 ins74N could still be undergoing intermolecular (trans) autophosphorylation. This point would need to be established by kinetic experiments, e.g. by measuring the concentration dependence of autophosphorylation.

9\) Figure 6D: the authors should present a quantification of the Western blots (the ratio of phosphorylated ERK1 to total ERK1).

10\) The activation loops of the ancestral kinases differ in length and sequence. Notably, the ancestral CDK.MAPK kinase has a -3 Arg residue, for which this kinase still has some residual preference. If canonical sequence-specificity is not relevant because of a cis-autophosphorylation mechanism, it is still worth noting that the sequence of the activation loop could affect activation loop dynamics. The authors should discuss how the composition of activation loop itself might impact their findings. This is somewhat addressed by the chimera experiments but would still be worth mentioning.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Ancestral reconstruction reveals mechanisms of ERK regulatory evolution\" for further consideration at *eLife*. Your revised article has been favorably evaluated by John Kuriyan (Senior Editor and Reviewing Editor), and three reviewers. The manuscript is now, in principle, suitable for publication in *eLife*, but the reviewers have identified some remaining issues that need to be addressed before acceptance, as outlined below. Please use your best judgement in revising the manuscript with reference to these points, and we will make a final decision as quickly as possible. When submitting the revised manuscript, please provide a point-by-point response to the review comments. Also, please add figure numbers to each individual figure in the submitted manuscript, and include page numbering on each page of the manuscript -- the lack of such numbering introduced an element of confusion in the review of the previous manuscript.

The premise of this study, that ancestral sequence reconstruction can be used to identify molecular mechanisms by which kinase regulation evolved, is quite intriguing. The authors do a nice job of exploring this premise within the MAP kinase family. The results are novel and of broad interest to the kinase field. Furthermore, the authors have adequately addressed most of the concerns raised after the original submission, although a few remaining points require attention before acceptance.

1\) A major issue is that for AncERK, AncJPE, AncMAPK, AncCDK.MAPK (which are evolutionary further from the modern proteins), still no posterior probabilities are provided. They need to be shown, as previously asked by the review. In addition, no experiments were performed to test for their phosphorylation status, and no experiments were done on their modern counterparts. Only activity was measured for these ancestors (Figure 1A), but their relation in respect to modern CDK, MAPK, *JNK*, p38 is not discussed either in the manuscript. Without the proper analysis on those ancestors the authors may wish to remove them and to keep the focus on the ERK ancestors. The latter is the story of this manuscript, and this part is interesting and convincing.

2\) The manuscript still does not correctly describe the quantification of the percentages of non-phosphorylated, single and double phosphorylated (TxY motif) proteins used in the activity studies. Figure 2---figure supplement 1B is provided, but one cannot follow what is exactly shown, and how these data can be used for quantification of phosphorylation. In the text it is described as \"more\" or \"less\" phosphorylation. Since differences in autophosphorylation is the center of the findings of this manuscript, this needs to be quantified accurately. Are these full-length proteins, or peptides shown in this figure, and the results of what kind of experiment are shown? Even ERK 1 appear to have some phosphorylation. What does \"modified TxY \" mean?

3\) The part of the manuscript pertaining to Point No. 4 in the \"Other Important Points\" in the original review, still needs further clarification in the manuscript. If this result is puzzling and currently cannot be explained unambiguously with a model, it is important to articulate this for the reader.

4\) The MD simulations are done on ERK2 (Figure 5), but all the experiments in the manuscript are performed on ERK1 (Figure 4). Why is this?

There is difficulty in seeing how the MD figures provided now help explain why the mutants of ERK1 autophosphorylate the TxY motive in cis much more efficiently than wtERK1. In Figure 5 all proteins have a bimodal distribution for the plotted distances (which are slightly altered). If one of these two substates is interpreted to be the active conformation, one would not expect the experimental result of a big difference in phosphorylation state between these proteins. The authors correctly note that there is no difference I domain closure either. These points should be clarified.
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Author response

> Major issues that must be addressed, with additional experiments as necessary:
>
> Although this is broken down into separate points, 1 to 6 below, all of these issues are related to putting the activities of the relevant kinases on a more rigorous footing. We ask that a substantial response be prepared for these questions, but the authors should judge whether particular experiments can be done in a realistic timeframe or not. Note that these questions are important, so a simple response that none of the experiments can be done in a timely fashion will not be deemed a satisfactory response.
>
> 1\) The authors use MBP phosphorylation as readout for intrinsic activity, but as in their previous paper, they show that each ancestral kinase has a slightly different substrate specificity. Is it possible that the differences observed for MBP phosphorylation are due to difference in sequence specificity, rather than intrinsic activity?

This is a good point. To check this possibility more carefully, we added two experiments. First, we expanded our specificity arrays to include AncERK1-5 (see new Figure 1---figure supplement 3). There is not much change in specificity between AncERK1-5 and ERK2. We were unable to get good specificity array data for AncERK1-2 due to low activity. However, we believe it unlikely that a major specificity change would occur from AncERK1-5 to AncERK1-2 and then back again from AncERK1-2 to ERK2. Nevertheless, we also checked the relative activities of AncERK1-5 and AncERK1-2 with a second substrate, ELK1: see the new Figure 1---figure supplements 4A and 4B. We see the same drop in activity from AncERK1-5 to AncERK1-2 with this second substrate. Taken together, we are confident that our results indicate changes in activity without a major contribution from specificity changes.

> 2\) In this assay, does MEK have any significant activity toward MBP? This should be measured as a control.

We tested this possibility and found that MEK has negligible toward MBP (Figure 1---figure supplement 2B). MEK is known to be highly specific for ERK, so we were happy to see this result. To further confirm that MEK can activate AncERK1-2, we co-expressed MEK and AncERK1-2, purified the ancestor away from MEK and found that this approach also led to increased AncERK1-2 activity (Figure 1---figure supplement 4C and 4D). Together, these experiments reinforce the conclusion that MEK can activate AncERK1-2.

> 3\) The activity measurements done in the paper are endpoint assays of myelin basic protein phosphorylation. For at least the key proteins (ERK1, AncERK1-5, AncERK1-2), the authors should carry out kinetic experiments. This would allow them to determine whether the effects are driven by changes in k~cat~, K~M~, or a combination.

We undertook the suggested characterization and found that the decrease in activity is due to a combination of increased K~M~ and decreased k~cat~. Interestingly, the values for AncERK1-2 look very similar to reported values of unphosphorylated ERK2 and the values for AncERK1-5 look very similar to phosphorylated ERK2 (Prowse and Lew, JBC, 2000). We have added these data to a new Figure 1D.

Prowse, C.N., and Lew, J. (2001). Mechanism of Activation of ERK2 by Dual Phosphorylation. J Biol Chem 276, 99--103.

> 4\) What are the phosphorylation states of each protein prior to the MBP phosphorylation reactions? It would be important to compare the activities of all proteins for the same phosphorylation states (nonphosphorylated versus doubly phosphorylated proteins). The activity data presented in Figure 1B represent the results of different mixtures of non- and phosphorylated kinases according to Figure 2B and C.
>
> For this, the quantification of phosphorylation for all samples need to be measured first, and then activity data collected for clean species (in Figure 2B and C, only a subset of proteins were characterized). Particularly AncERC1-5and AncRC1-2 are missing in respect to analysis of differential phosphorylation rates, the crucial proteins where the switch seem to happen in evolution.

We characterized the phosphorylation state of the TEY motif in AncERK1-5 and AncERK1-2. We added these data to Figure 2D. AncERK1-2 is almost completely unphosphorylated and AncERK1-5 is highly phosphorylated (consistent with the K~M~ and k~cat~ data reported above).

> 5\) A distinction should be made throughout the manuscript between \"intrinsic activity\" and regulation by activation loop auto-phosphorylation. Differences in \"intrinsic activities\" would ideally be assessed by comparing the enzymatic activities of all kinases in the same phosphorylation states. In other words, how active are each of the unphosphorylated kinases, and how active are those same kinases after activation loop phosphorylation? What the authors are measuring in the beginning of the Results section, and in Figure 1B, appears to be the consequence of a difference in the ability to auto-phosphorylate and thus auto-activate, not necessarily a difference in intrinsic activity.

Thank you for pointing this out. We believe we are really looking at differences in phosphorylation state due to differential autophosphorylation (see above experiments). We have updated this language and interpretation in the text.

> 6\) Related to these points, it would be informative to see raw data (phosphorimages) from the MBP phosphorylation reactions in Figure 1B as a figure supplement, rather than just a normalized quantification of endpoint intensities.

We have added examples of these raw data to the Figure 1---figure supplement 2A.

> 7\) Finally, we ask that the amino acid sequences of all proteins (modern and resurrected) be included in the supplementary materials, and it would be of value to give the number of substitutions in the text. The full tree used for ancestral sequence reconstruction (ASR), including the species, needs to be included for reproducibility for the field. A supplementary figure that shows the probabilities of the nodes, and information of the posterior probabilities for the full sequences is essential to evaluate ASR.

We have added a supplementary figure with the posterior probabilities of the reconstructions for each of the kinases studied (Figure 1---figure supplement 1). We have also provided a link to all reconstruction data including the full trees, sequences for every ancestor and all probabilities: [http://phylobot.com/350478581/msaprobs.PROTCATLG/ancestors]{.ul}

> Other important issues that require response:
>
> 1\) The authors should avoid language that implies that the ancestral protein sequence is actually known. A sophisticated reader will understand what is meant, but we are concerned that the way that much of the paper is written a strong impression is given that the ancestral sequence is actually synthesized. This is not just a semantic point, because it may turn out that errors in the sequence reconstruction have led to misleading results. We do not consider this point to invalidate the conclusions of this study, but we ask that the language used to describe the \"ancestral\" sequences be changed throughout the manuscript. A few comments, given below, should help explain what we mean.
>
> The method of ancestral sequence reconstruction is a powerful approach to dissect molecular differences between closely-related biomolecules. However, the use of the dramatic term \"resurrection\" should be avoided throughout this manuscript, as it implies that we have explicit knowledge of the true protein sequences found in ancestral organisms, which is then \"resurrected\". The more common term, \"reconstruction\", is more appropriate, as it indicates that a sequence model of a plausible ancestral protein is being generated using the best available evidence. An example of a statement that implies that the ancestor is truly known, and that the authors should avoid is the following:
>
> \"As part of this study, we observed that a deep ancestor of this group had relatively high intrinsic activity even in the absence of any activating kinase of or allosteric activators.\"
>
> In the beginning of the main section of the paper, the authors use the following phraseology, which correctly captures the inherent uncertainty in the \"resurrected\" sequences: \"We synthesized the coding sequences for these inferred ancestors\".

We have reworded the manuscript to better reflect these uncertainties and removed the term "resurrection".

> 2\) The manuscript is focused on the specific late evolution between ERK5 and ERK 1 and 2, and there is no information about the evolution of regulation towards CDKs, MAPKs, JNK, p38. Therefore the Introduction, Abstract and title should be modified to reflect the data from this manuscript (for instance: \"Ancestral resurrection reveals mechanism of kinase regulatory evolution of ERK\").

We have changed the title to reflect the focus on ERK.

> 3\) To enlighten the reader about the evolutionary trajectory, key information to add would be how modern ERK5, ERK 7 that branch off the ancestors used in this study are behaving in respect to activities of their nonphosphorylated and phosphorylated activation loop states towards substrates, and their ability to autophosphorylate.

We have added language to indicate the high basal activity of ERK5 and ERK7 to the text.

> 4\) What is the explanation of a much higher activity of AncERK1-2 with the two mutations in the presence of MEK relative to AncERK1-2 in the presence of MEK? Could the authors also include the data for the reverse experiment, AncERK1-5 M89Q 44Rdel, both in the absence and presence of MEK, in Figure 3?

This is a good question. We have added experiments to address this issue. Adding MEK to the AncERK1-2 Q89M ins44R doesn't increase the kinase activity much. Adding MEK to AncERK1-2 increases activity \~6 fold, but this leads to \< 10% of the activity of the active mutant. We believe that this inefficiency is due to the known high specificity of MEK for ERK1 and 2. We speculate that MEK doesn't recognize AncERK1-2 as efficiently, accounting for the lower efficiency of activation of AncERK1-2.

We tried experiments adding MEK to AncERK1-5 (Figure 3---figure supplement 5) and saw only a slight potentiation. We also added MEK to AncERK1-5 M89Q del44R and again saw only an \~2-fold increase in activity. It is likely that AncERK1-5 is an even worse substrate for MEK than AncERK1-2. We have added these experiments to Figure 3---figure supplement 5.

> 5\) 300 ns trajectories are very short MD simulations, and it is quite unlikely that refolding of the L16 loop coupled to domain closure is on that time scale. NMR data for ERK has suggested that these processes occur on the millisecond time-scale. Thus, the MD simulations are not convincing due to the discrepancy in time scale between the suggested conformational changes and the length of the simulations, and rather weaken the manuscript than strengthen it. The authors should consider carefully what information is contributed by the MD simulations, and then describe that with appropriate cautionary notes. Alternatively, remove the MD simulations from the manuscript.

We have greatly expanded our MD analysis using roughly three orders of magnitude more data. We performed extensive analyses of multiple (1,000) long MD simulations per sequence, generating \~500 microseconds aggregate simulation data for each sequence, and compared the WT and mutants. In total, we generated and analyzed a total of \~ 2 ms of aggregate simulation data.

We did not observe a sufficient number of very slow conformational rearrangements (e.g. DFG flips or large-scale domain motion) to be able to construct a Markov state model of the complete conformational dynamics. Therefore, we have taken care not to make such claims in the manuscript. However, this new far larger simulation dataset (\> 3 orders of magnitude more than the previous experiment) is consistent with the leading edge of what has been done for biomolecular simulations of kinases, e.g., compare to the Scientific Reports paper from Sultan and Pande where they have 1.7 ms aggregate from the simulation of two kinase sequences (we have \~ 2 ms for 4 sequences):

Sultan, M.M., Denny, R.A., Unwalla, R., Lovering, F., and Pande, V.S. (2017). Millisecond dynamics of BTK reveal kinome-wide conformational plasticity within the apo kinase domain. Sci Rep *7*, 15604.

We are happy to report that the more active configuration of catalytic residues is maintained in these much more extensive data (Figure 5D-F). We can also clearly see synergy between the two mutations. Furthermore, each mutation gives increased flexibility at two points in the kinase (Figure A-C). While we can't comment on domain closure and have therefore removed this language, we do see increased variance in domain angles (Figure 5G). These last data are presented with strong caveats. We believe these data provide starting points for future biochemical and simulation work and therefore are valuable to the study.

These new data were obtained in collaboration with John Chodera and Rafal Wiewiora at MSKCC, therefore they are now included as co-authors on the study. They have seen and approved the manuscript and are in agreement with their placement in the author list. They collaborated with Myvizhi Selvan, a new postdoc in the lab of Zeynep Gumus, therefore she is now added as an author. The work of Selvan Vatansever was removed from the manuscript following earlier criticisms and as a result she did not ultimately contribute to the data in the projects, therefore she has been removed as an author. All of these changes have been approved by the laboratories involved.

> Should the MD simulations be retained, the authors should clarify what atoms are being used to measure the distances between residues in the analyses of MD simulations. In particular, for salt bridges, as in the one analyzed in Figures 5C, F, it would be most informative to look at distances between terminal or near-terminal atoms of the side chains (e.g. the terminal nitrogen of the lysine sidechain and the δ carbon or one of the oxygens of the glutamate residue).

We are indeed using the nearest neighbor heavy (non-hydrogen) atoms. We have added this language to the text.

> 6\) The figures could be better arranged and assembled, it is hard to jump back and forth between gels and activity figures. Could all data be presented in a quantitative format (activity towards MBP and autophosphorylation)?

We have added the data in more quantitative format where possible.

> 7\) The authors should include an LC/MS quantification of TEY motif phosphorylation for AncERK1-5 and AncERK1-2 (i.e., a similar analysis as was done in Figure 2C).

We have added these data in Figure 2D.

> 8\) Figure 4E does not conclusively establish the mechanism of autophosphorylation; His6-ERK1 ins74N could still be undergoing intermolecular (trans) autophosphorylation. This point would need to be established by kinetic experiments, e.g. by measuring the concentration dependence of autophosphorylation.

We have added these data in Figure 4---figure supplement 4. The concentration dependence of autophosphorylation is consistent with intramolecular autophosphorylation.

> 9\) Figure 6D: the authors should present a quantification of the Western blots (the ratio of phosphorylated ERK1 to total ERK1).

We have added this quantification.

> 10\) The activation loops of the ancestral kinases differ in length and sequence. Notably, the ancestral CDK.MAPK kinase has a -3 Arg residue, for which this kinase still has some residual preference. If canonical sequence-specificity is not relevant because of a cis-autophosphorylation mechanism, it is still worth noting that the sequence of the activation loop could affect activation loop dynamics. The authors should discuss how the composition of activation loop itself might impact their findings. This is somewhat addressed by the chimera experiments but would still be worth mentioning.

We have added text that discusses this possibility in the section on chimeric kinases.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> \[...\] 1) A major issue is that for AncERK, AncJPE, AncMAPK, AncCDK.MAPK (which are evolutionary further from the modern proteins), still no posterior probabilities are provided. They need to be shown, as previously asked by the review. In addition, no experiments were performed to test for their phosphorylation status, and no experiments were done on their modern counterparts. Only activity was measured for these ancestors (Figure 1A), but their relation in respect to modern CDK, MAPK, JNK, p38 is not discussed either in the manuscript.

We have added this discussion (subsection "Reconstruction of the lineage leading to ERK kinases").

> Without the proper analysis on those ancestors the authors may wish to remove them and to keep the focus on the ERK ancestors. The latter is the story of this manuscript, and this part is interesting and convincing.

We discuss the regulation of p38, ERK1-2 and CDKs in the Introduction as well as the outgroups DYRK and GSK groups of kinases.

We have added the posterior probabilities for all of these ancestors (Figure 1---figure supplement 1). We have also performed extensive additional mass spectrometry and have analyzed the phosphorylation status and added these results (new Figure 2C). Therefore, we have kept the deeper ancestors in the paper (additionally the specificity analysis in Figure 1---figure supplement 3 is valuable for future studies on the evolution of kinase specificity).

> 2\) The manuscript still does not correctly describe the quantification of the percentages of non-phosphorylated, single and double phosphorylated (TxY motif) proteins used in the activity studies. Figure 2---figure supplement 1B is provided, but one cannot follow what is exactly shown, and how these data can be used for quantification of phosphorylation. In the text it is described as \"more\" or \"less\" phosphorylation. Since differences in autophosphorylation is the center of the findings of this manuscript, this needs to be quantified accurately. Are these full-length proteins, or peptides shown in this figure, and the results of what kind of experiment are shown? Even ERK 1 appear to have some phosphorylation. What does \"modified TxY \" mean?

We agree, these data were quite unclear before. We quantified tryptic peptides in this analysis. We have updated the Materials and methods section and manuscript to clarify these points (subsection "The higher basal activity of deep inferred ancestors is due to autophosphorylation of the TxY motif", Figure 2 legend and Materials and methods). We have also reanalyzed all of our data and presented the fraction of pT-E-Y, T-E-pY, and pT-E-pY (e.g. where pT is phosphothreonine) for all experiments. We include the precise sequences and modifications of all peptides in Source data 1.

> 3\) The part of the manuscript pertaining to Point No. 4 in the \"Other Important Points\" in the original review, still needs further clarification in the manuscript. If this result is puzzling and currently cannot be explained unambiguously with a model, it is important to articulate this for the reader.

The original question was: 4. What is the explanation of a much higher activity of AncERK1-2 with the two mutations in the presence of MEK relative to AncERK1-2 in the presence of MEK? Could the authors also include the data for the reverse experiment, AncERK1-5 M89Q 44Rdel, both in the absence and presence of MEK, in Figure 3?

Our reply was: This is a good question. We have added experiments to address this issue. Adding MEK to the AncERK1-2 Q89M ins44R doesn't increase the kinase activity much. Adding MEK to AncERK1-2 increases activity \~6 fold, but this leads to \< 10% of the activity of the active mutant. We believe that this inefficiency is due to the known high specificity of MEK for ERK1 and 2. We speculate that MEK doesn't recognize AncERK1-2 as efficiently, accounting for the lower efficiency of activation of AncERK1-2.

We tried experiments adding MEK to AncERK1-5 (Figure 3---figure supplement 5) and saw only a slight potentiation. We also added MEK to AncERK1-5 M89Q del44R and again saw only an \~2-fold increase in activity. It is likely that AncERK1-5 is an even worse substrate for MEK than AncERK1-2. We have added these experiments to Figure 3---figure supplement 5. We have now added this discussion to the subsection "Shortening of linker loop and mutation of gatekeeper residue led to tight regulation in the ERK1-2 family".

> 4\) The MD simulations are done on ERK2 (Figure 5), but all the experiments in the manuscript are performed on ERK1 (Figure 4). Why is this?

This is because we have crystal structures of unphosphorylated ERK2 but not of ERK1. We chose to focus our analysis on unphosphorylated kinase as we decided the initial autophosphorylation would be most relevant. Furthermore, there was previous MD simulation work and mechanistic suggestions on ERK2 autophosphorylation (Barr, et al., 2011 and Emrick, et al., 2006), hence we decided it would be most valuable to extend this research direction on the same system.

We have performed biochemical experiments with ERK2 and obtain similar results as with ERK1, i.e. the same gatekeeper and insertion mutations lead to increased activity due to higher basal phosphorylation. Therefore, we believe that results that we obtain with the ERK2 structure will be relevant to both ERK1 and ERK2. We have added the ERK2 experiments to Figure 5---figure supplement 1. We have also now explained our reasoning in the manuscript (subsection "Molecular dynamics simulations reveal increased flexibility at the glycine rich loop and loop 16, and a higher probability of an active organization of catalytic residues in mutant kinases", first paragraph).

> There is difficulty in seeing how the MD figures provided now help explain why the mutants of ERK1 autophosphorylate the TxY motive in cis much more efficiently than wtERK1. In Figure 5 all proteins have a bimodal distribution for the plotted distances (which are slightly altered). If one of these two substates is interpreted to be the active conformation, one would not expect the experimental result of a big difference in phosphorylation state between these proteins. The authors correctly note that there is no difference I domain closure either. These points should be clarified.

We have performed the MD simulations to explore some of the structural changes influenced by the mutants and suggest hypotheses for further mutational studies. While these simulations were extensive and long (2.05 ms in aggregate from 4,000 MD simulations for four systems), they were still not long enough to sample and capture some of the conformational changes that occur on a millisecond scale, such as domain closure. Hence, the data clearly do not describe the true (global) equilibria of the systems, rather it is informative about the neighborhood (local equilibrium) of the inactive conformation. While not offering definitive explanations as to the full autophosphorylation activation pathway, the data show the relaxation processes of the mutated systems that would eventually lead to the global equilibrium. Hence, it is not surprising that we observe only small changes to the conformational ensembles at these limited timescales, and with more sampling we expect the differences to keep increasing until we have described the full activation mechanism leading to the experimental magnitude of change in activity. However, knowledge of the initial stages of this relaxation process towards the global equilibrium, particularly the patterns of residue-residue contact disruptions, would provide enough information to make informed hypotheses about mutations that can further tweak the behavior of the protein.

To maximize the understanding of the structural changes seen in the current datasets, we have now developed Markov state models (MSM) trained on the inter-residue distances corresponding to contacts most relevant to distinguishing the conformational ensembles of the four protein systems from each other. MSMs help integrate information from multiple simulations to reveal the system's kinetically distinct macrostates, whose populations can be perturbed by mutations. The MSMs revealed how different structural changes caused by the mutants are kinetically coupled with each other. Again, these insights will allow for generation of further mutational hypotheses to further study structural aspects of the autophosphorylation activation process.

In addition to the mutants promoting formation of active-like conformations, cis-autophosphorylation requires that the phosphorylation sites be able to intramolecularly reach the active site -- a mechanism of activation lip destabilization leading to that has been previously proposed (Emrick et al., 2006). We have analyzed our data according to this proposed mechanism, and found the presence of small populations of conformations where the phosphorylation site tyrosine can access the active site aspartate in all systems. We did not observe other changes proposed by the mechanism, instead we analyzed the patterns of contact changes in our simulations at the activation lip and indicate crucial residues for future mutational studies.

We have updated the text to indicate the observations and limitations of our current MD simulation. The results of these simulations will be used in future studies as seeds for adaptive sampling to generate MSMs describing all relevant activation steps involved, and to generate first guesses at reaction coordinates for enhanced sampling. We note that a description of the full activation mechanism would be a significant research project in itself, and is far outside the scope of this work.
